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ABSTRACT

In the United States, 1 out of every 9 death certificates in 2013 referenced heart
failure.1 Despite the outstanding need of treatment options for heart failure, heart
transplantation remains the optimal treatment method. However, there is a severe
shortage of donor hearts available for transplantation.2 Other available treatment options
are not ideal because they do not fully restore function and are associated with creating
other complications.3 Thus, there is a need for developing a living tissue engineered
whole heart for transplantation to provide an alternative option for patients on the waitlist
to receive a donor heart.
Our solution is to create acellular myocardial tissue scaffolds seeded with
autologous cells corresponding to the patient’s heart. Once the cell seeded scaffold is
conditioned and prepared to support life, it would not elicit an immune response postimplantation. The goal of this project is to reconstitute the endocardium in both ventricles
of decellularized rabbit myocardium with clinically relevant cell types and hydrogels.
We first developed a bi-ventricle perfusion decellularization procedure which
yielded fully acellular hearts. The shape, architecture, and most of the extracellular
matrix components of the scaffolds were preserved. Some minor drawbacks included
partial removal of the basal lamina components and increased scaffold porosity.
Next, we performed a series of cell seeding and hydrogel infusion experiments to
develop a procedure for delivering the necessary components for rebuilding the
endocardium. To help us reach our goal, several devices were designed and developed
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along the way including a 3-D printed stand and funnel for gravitational seeding and a
rotational bioreactor system. Our final procedure utilized a layer-by-layer method for
administering human endothelial cells, human fibroblast cells, collagen hydrogel, and
fibrin hydrogel. Using different analysis techniques, we found hydrogels infused onto the
surfaces of the ventricle cavities and cells affectively adhered to the linings of ventricles
while remaining active through secreting matrix proteins. However, we could not fully
cover the entire surfaces of the ventricles with our tissue engineered endocardium. Future
work will be geared towards developing a uniform inner lining of the ventricles.
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CHAPTER ONE
INTRODUCTION

1.1 Background
1.1.1 Anatomy
The heart wall is composed of three layers. The epicardium forms the outside
layer of the heart, the myocardium forms the middle layer of the heart, and the
endocardium forms the inside layer of the heart. Each layer is composed of a unique
composition and structural that serves a specific function required to maintain a healthy
heart.
Briefly, the epicardium or visceral pericardium, forms the outer membrane of the
heart. Along with the parietal pericardium, the epicardium lines the pericardial cavity.
The epicardium can be divided into two layers. A mesothelium layer covers the entire
surface of the pericardial cavity and forms the outermost portion of the epicardium.
Underneath the mesothelium surface of the epicardium, areolar connective tissue forms
the subepicardial layer and intimately adjoins to the myocardium.4,5 Both adipose and
fibrous connective tissue constitute the areolar connective tissue. Inside the subepicardial
layer several lymphatic vessels, blood vessels, and nerves can be found.5
The primary function of the heart is to pump blood through the circulatory
system. Repeated diastolic and systolic rhymes that make up the contractions are
governed by the myocardium. Electrochemical stimulations induce the cardiac muscle
fibers to contract and force the movement of blood. Purkinje fibers integrated into the
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heart muscle are responsible for this stimulation and serve to maintain synchronized
contractions amongst the cardiac muscle fibers. The myocardium is the thickest layer of
the heart that lies in between the epicardium and endocardium. However, the thickness of
the myocardium is not universal for each of the four chambers of the heart. The pressure
present in each chamber correlates to the thickness of that chamber.5 Cardiomyocytes are
the primary cell type found in the myocardium. Cardiac muscle fibers are formed by
cardiomyocytes connected in a long row adjoined to each other by intercalated discs.
Interestingly, in the left ventricle, cardiac muscle fiber angles transition from epicardium
to endocardium. The cardiac muscle fiber angles vary from about -60˚ from the
circumferential axis at the epicardium to about +70˚ from the circumferential axis at the
endocardium.6
The endocardium is the focus of this project and will be the emphasis of the
remainder of the anatomy subchapter. The endocardium is a multilayered tissue that has
been established since the nineteenth century when Bouillaud coined the term
endocardium to contrast the internal membrane of the heart with the pericardium.7 There
are two layers that comprise the endocardium. The first is the endothelium. Endothelial
cells are polygonal squamous and form tight junctions with one another to create a
monolayer that encompasses the full blood contacting surface of each chamber of the
heart.8 The endothelium functions to prevent thrombosis from forming similar to the
endothelium found in blood vessels. Beneath the endothelial monolayer exists an electron
dense basal lamina for connecting endothelial cells to the underlying tunica propria.8,9
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The tunica propria is the second layer of the endocardium. In this layer, fibroblast
become the most prominent cell type.8 This subendothelial layer is constructed by loose
connective tissue with unmyelinated nerve fibers dispersed throughout. The loose
connective tissue is primarily composed of collagen in single or multiple unit fibrils
arranged either parallel to the ventricular surface or randomly oriented in the ground
substance.8 Nagayo (1909) described the tunica propria as divided into 3 or 4 sublayers
depending on the chamber of the heart. In the left ventricle, the first sublayer is an inner
connective tissue layer followed by an elastic sublayer. Beneath the elastic sublayer, there
is a smooth muscle sublayer and an additional connective tissue sublayer before reaching
the myocardium. However, in the atria, the smooth muscle sublayer does not exist.10
Interestingly, in rat hearts, Melax (1967) did not find an elastic sublayer. Instead, he only
found elastic clumps at the junction between the aorta and the endocardium.8 This
suggest a slight difference in endocardial anatomy between mammalian species. At the
border of the endocardium and the myocardium, the endocardium is anchored by the unit
membrane of muscle cells that act as both sarcolemma and an extracellular basement
membrane.8
The overall surface of the endocardium is extremely irregular. Papillary muscles
and trabeculae carneae form random orientations by crisscrossing along the surface.
Interlacing fiber bundles create a curvy membrane consistent with multiple bulging
portions and valleys in between.11,12 In the human heart, the thickness of the endocardium
slightly varies within each chamber and greatly varies among chambers. OKADA (1961)
found the average thickness to be 10µm-20µm in the left ventricle, 7µm-10µm in the
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right ventricle, 300µm and 100µm in the left and right atrium respectively. Additionally,
he found there are correlations for increasing thickness of the endocardium with
increasing age of the person and increasing thickness of the aortic valvular leaflet.13

Figure 1: The anatomy and structure of the heart wall. The endocardium is
positioned on the left side beginning with the endothelium. In the middle, the
myocardium is shown. The right side depicts the pericardium, pericardial cavity, and
epicardium. Image courtesy of anatomygroup.wordpress.com
Throughout history, the endocardium has been neglected amongst researchers.
This is in part because the endocardium has been regarded as only having the function of
an endothelium. However, the endocardium may function as more than a tightly sealed
blood contacting surface. In fact, the endocardium may provide feedback to modulate the
myocardium’s mechanical performance through direct exposure to the circulating
bloodstream.12,14 Regulation of ion and water exchange between the myocardium and
bloodstream may be an additional function of the endocardium. Although much of this
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substance exchange may occur via the coronary vasculature, the intercellular clefts in
between the endothelial cells of the endocardial endothelium may play a role in
regulating this ion/water flux through variations in cleft size.12 The endocardium has
been suggested to be more intimately involved with myocardium than previously thought.
Through direct or in-direct pathways, the endocardium may act as a sensory mechanism
to influence cardiac performance.12 However, due to lack of research conducted on the
endocardium, these mentioned functions lack the evidence to be proven.
Although much of the endocardium’s functions remain unknown or unproven,
there has been sufficient evidence to show a correlation between diseases of the heart and
health of the inner membrane of the heart. Pathological consequence of various diseases
have been shown to impact the endocardium.13 Myocardial Infarction (MI), dilation,
hypertrophy, endocarditis, and unusually high jet stream have been shown to be
disruptive to the endocardium.13,15,16 Damage to the endocardium leads down a pathway
towards thrombogenic fibrosis and eventually endocardial thickening.13 Ultimately, due
to the high rate of occurrence for MI each year, MI may be responsible for many cases of
endocardial thickening worldwide.

1.1.2 Etiology
Myocardial Infarction (MI) is a disease responsible for many deaths and
disabilities across the world. More than 7 million people worldwide are estimated to have
some form of MI each year17. In Europe, every seventh woman and every sixth man will
die due to MI.18 In the United States close to 900,000 people are diagnosed with MI each
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year and close to a quarter of them die.19 After the first few hours following MI, many
patients die due to ventricle fibrillation because they are unable to make it to the hospital
in time for treatment.18
There are many causes of MI. The most common cause of MI occurs due to
partial or complete occlusion in a coronary artery from erosion or rupture of plaques,
which causes 70% of deaths related to MI.17,20 Other common causes of MI occur from
emboli, coronary spasm, or dissection of a coronary artery.20 According to a study by
Yusuf (2004), several risks factors have been identified for attributing to the occurrence
of MI. He determined nine risk factors, which can be potentially altered through
treatments and lifestyle changes, attributing to 90% of the risk of the first occurrence of
acute MI. These nine risk factors are: smoking, consumption of fruit and vegetables,
alcohol consumption, exercise, diabetes, hypertension, dyslipidemia, abdominal obesity,
and psychosocial. He discovered smoking and dyslipidemia are the two most impactful of
the risk factors.21
MI was identified as a disease in the 1970s and characterized by plaque rupturing,
causing thrombosis, and resulting in the occlusion of a vessel in the coronary
vasculature.22 Since then, mostly due to the advancement of technology available to
clinicians, extensive research into the topic, and new treatment options, the definition of
MI has evolved to encompass multiple circumstances leading to myocardial ischemia.
Five classifications have developed for the different types of MI identified since
the 1970s. The first type is as mentioned previously in this paper, caused by plaque
erosion/rupture. The second type is caused by lack of oxygen supply.23 Oxygen demand
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in the myocardium can change due to arrhythmias, coronary artery spasm, hypertension,
and other factors. The third classification results in an unexpected death of the patient
with signs of myocardial ischemia.23 In this scenario, the patient died before blood
samples could be analyzed or imaging techniques could be used to identify MI. The
fourth and fifth type of MI occurs to due intervention. The fourth pertaining to
percutaneous coronary intervention (PCI) or stent thrombosis and the fifth pertaining to
coronary artery bypass graft (CABG) procedure.23 Across all five classifications of MI
the common theme linking them all together is cardiac myocyte death due to ischemia.

Figure 2: Depiction of MI. An occluded coronary artery causes an ischemic area
downstream of the occlusion in the myocardium. Image courtesy of nurseslabs.com

Pathology 1.1.3
Once a patient has been diagnosed with a type of MI, the disease can be further
classified by considering the pathological features presented by the patient. MI can be
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identified pathologically as acute, in the progress of healing, or healed.23 Typically acute
MI is the optimal condition for reperfusion to minimize cardiac cell death and healing MI
is the optimal condition for regenerative treatments to minimize the remodeling process.
From the moment ischemia occurs up to six hours, the pathological identification
is acute MI.23 After six hours, the cytokines released by injured myocytes recruit
fibroblasts and mononuclear cells through chemotaxis to the ischemic area and induces
fibroblast proliferation.17,19,23 When these cells are present, MI can be pathologically
classified as healing.23 According to Sutton (2000), the growth factors released by
macrophages and necrotic myocytes induce the fibroblast to differentiate into
myofibroblasts. Remodeling then takes place through collagen degradation by matrix
metalloproteinases and secretion of collage type I and III by the differentiated
myofibroblasts. After the fibrous tissue replaces the necrotic tissue, collagen formation
becomes less occurrent and myofibroblasts are induced to partake in apoptosis.24 Once
acellular fibrous scar tissue has formed, typically occurring after 5-6 weeks, MI is
considered healed.23
Myocardial tissue is less capable of regeneration compared to other tissues in the
body.25 After myocytes undergo necrosis, the heart experiences an increase in loading
conditions and wall stresses. Through biochemical signaling, these loading conditions are
counteracted by the formation of acellular scar tissue, dilation, and hypertrophy.24
Hypertrophy and the enlargement of the ischemic area occurs through degradation of
collagen struts causing slippage of necrotic myocytes.24,26 Remodeling and the formation
of scar tissue will continue until elevated wall stresses are evenly distributed by the
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collagen scar tissue and the distending forces and increased loading conditions are
balanced.24 The extent of collagen cross-linking to strengthen the acellular fibrous tissue
is determined by the mechanical stimuli experienced by remodeled area.27 Hypertrophy,
dilation, and formation of acellular scar tissue will ultimately lead towards congestive
heart failure. A big clinical challenge dealing with MI is preventing scar tissue formation
and impeding progress towards congestive heart failure (CHF).

1.1.4 Diagnosis
Diagnosis is important for treating MI. Having the capability of identifying and
locating small areas of myocardial necrosis will improve patient outcomes by recognizing
the need for treatment prior to the progression of unfavorable cardiac function during the
remodeling phase. It is important to classify MI into two categories to be referenced later,
ST-segment elevations myocardial infarction (STEMI) and non-ST-segment elevations
myocardial infarction (NSTEMI). These classifications are created based on the method
used to diagnose MI. STEMI refers to the PQRST wave on an electrocardiogram.
Patients experiencing MI will sometimes exhibit an extended period between the ending
of the QRS wave and the beginning of the T wave. NSTEMI refers to patients that do not
exhibit this apparent change in the PQRST wave but are still diagnosed with MI.
Additional diagnostic methods used to identify MI in patients are evaluation of
biomarkers and imaging techniques.
Damaged myocytes release different proteins into the blood circulation that can
be evaluated as biomarkers, such proteins include cardiac troponin T and I, LDH, CK,
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CKMB, myoglobin and others.28 Out of these biomarkers, the most reliable is troponin I
and T. Troponin I and T are highly specific to myocardial tissue and can be used to
identify small areas of myocardial necrosis.23 The second-best biomarker to use for
diagnosing MI is CKMB. CKMB is primarily secreted in cardiac tissue but can also be
found in skeletal tissue.23 The lack of exclusive secretion in myocardial tissue may lead
to a missed diagnosis using CKMB. The worst biomarker to use for MI is CK because it
is not very specific to myocardium and has a large prevalence in skeletal muscle.23
Multiple imaging techniques can be used for diagnosing MI and present the
advantage of being noninvasive. Frequently used imaging techniques are radionuclide,
myocardial perfusion scintigraphy, echocardiography, ventriculography, and magnetic
resonance imaging. Less frequent imaging techniques used are X-ray computed
tomography and positron emission tomography.23 A more invasive but frequently used
imaging technique is angiography. In this technique, a contrast die is released from a
catheter in front of the coronary arteries in the aorta. The die will flow through the
coronary vasculature visualized by X-ray imaging. Areas of occlusion are easily
recognizable using this approach. Compatibility with PCI is another big advantage of
angiography. Using this technique, PCI can be administered immediately following the
recognition of an occluded coronary artery.
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Figure 3: Depiction of an angiogram. A catheter releases a radiopaque die in front of
the coronary arteries. X-ray imaging is then used to discover areas of occlusion (arrows).
Image courtesy of shalby.org

1.2 Current Treatment Options
1.2.1 Coronary Artery Bypass Graft (CABG)
CABG was developed in 1968 and became the gold standard for treating coronary
artery disease29. However, this procedure’s surgery rate has been steadily declining since
the early 2000s.30,31 Currently, there is a small number of patients who undergo CABG
with STEMI. CABG is required for MI patients whose anatomy is not compatible with
PCI. Also, the patency of the occlude artery must allow for enough time for the MI
patients to be transferred to a surgical team.18 Therefore, CABG is used to treat coronary
artery disease but not frequently used as the first choice of treatment for MI.
The invasiveness, recovery time, and time between first medical contact and
successful reperfusion are the biggest disadvantages associated with CABG. During
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CABG, a blood vessel must be dissected from the patient and sewed onto the heart. The
blood vessel is usually cut from the saphenous vein or chest wall. To sew the graft onto
the heart, one end of the blood vessel is attached to the aorta and the other end is attached
downstream of the occluded coronary artery. This allows for a bypass of the blockage in
the coronary artery by restoring blood flow to the ischemia area affected by the
occlusion.

Figure 4: Coronary Artery Bypass Grafting (CABG). A coronary artery bypass graft
is attached to the aorta and attached downstream of the coronary artery occlusion. Image
courtesy of hopelandmedicaltourism.com

1.2.2 Fibrinolysis and Thrombolysis
Fibrinolysis and thrombolysis utilize drugs to dissolve the blood clot causing the
occlusion in the coronary vessel. The difference between the two techniques are the
targeted components of the blood clot. Fibrinolysis targets the fibrin content and
thrombolysis targets the thrombin content. Streptokinase and tissue plasminogen activator
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are examples of drugs used for fibrinolysis. Unfractionated heparin is an example of a
drug used for thrombolysis. These drugs can be administered intravenously or through a
catheter at the location of the clot. Additionally, the catheter can be equipped with a
mechanical device used to physically break up the clot. Thrombolysis and Fibrinolysis
have both been proven to be beneficial for patients experiencing acute MI.32,33 Majority
of patients presenting STEMI will benefit from thrombolysis if the procedure is
conducted within 12 hours of symptom onset.32 Decreased mortality and left-ventricular
function perseveration have been seen in patients who undergo thrombolytic therapy as
compared to a control.32 When compared to a placebo, fibrinolysis has been shown to
reduce 30 early deaths for every 1000 patients if the patients are treated within 6 hours of
symptom onset.18,33 Compared to PCI and CABG, fibrinolysis and thrombolysis can be
administered quicker. Therefore, the relatively fast time to reperfusion is the biggest
advantage associated with fibrinolysis and thrombolysis.

Figure 5: Fibrinolysis/thrombolysis. A catheter is guided into place at the site of a
blood clot in a peripheral vein. The catheter releases a drug to dissolve the blood clot.
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This procedure can also be conducted for reperfusion post-MI. Image courtesy of
saintlukeshealthsystem.org

1.2.3 Percutaneous Coronary Intervention (PCI)
PCI was first introduced in 1977.29 When PCI is the first treatment method used
for an occurrence of MI, it is considered primary PCI. A key advantage of PCI is its
compatibility with angiography. As previously mentioned, angiography is frequently
used to diagnose MI. Primary PCI can be immediately administered following
confirmation of MI diagnosis with angiography.18 When compared to thrombolysis and
fibrinolysis, PCI has been shown to reduce the occurrence of short-term adverse cardiac
events.17,34 However, a disadvantage of PCI is its inability to be administered as quickly
as thrombolysis and fibrinolysis. One study by De Luca (2004) has shown that every
minute of time delay for treating STEMI affects the one year mortality rate of the
patients.35 This increasing mortality rate holds true for both thrombolytic and fibrinolytic
therapies as well as primary PCI. This suggests there is a time limit for the benefits to
hold true in waiting for primary PCI treatment as opposed to immediate treatment with
thrombolysis or fibrinolysis, especially with high risk patients.17 Currently, primary PCI
is considered the optimal treatment option if PCI can be administered within 120 minutes
of first medical contact. Otherwise, fibrinolysis or thrombolysis is considered to be the
optimal treatment given there are no contraindications associated with the patient for
administering the fibrinolytic or thrombolytic agent.18
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PCI can also be used as a secondary approach for treating MI. In a secondary
approach, PCI is administered following fibrinolysis or thrombolysis. In rescue PCI, PCI
is performed following fibrinolysis when signs of failed reperfusion are present versus
when recurrent ischemia occurs. Lower rates of death, reinfarction, and heart failure have
been associated with rescue PCI compared to repeat fibrinolytic therapy at a 6 month
follow up. However, PCI as opposed to repeat fibrinolytic therapy, was associated with
an increased risk of minor bleeding and stroke.36 Additionally, secondary PCI has been
used as an immediate follow up to fibrinolysis. This technique is known as facilitated
PCI. However, facilitated PCI has not shown promising results.17
Over the years PCI has evolved to encompass several different approaches to
restoring blood flow. Balloon angioplasty, bare metal stents, drug eluting stents, and drug
eluting balloons are some of the different technologies that have been produced to
improve post-surgery outcomes of PCI. The two most widely used drugs in drug eluting
stents and balloons are sirolimus and paclitaxel. One study by Stettler (2007) compared
the clinical outcomes of using Bare Metal Stents (BMS), Paclitaxel Eluting Stents (PES),
and Sirolimus Eluting Stents (SES). He found each of the three types of stents had similar
cardiac mortality, with SES being associated with a decrease risk of MI and PES being
associated with an increase occurrence of late thrombosis.37 Additionally, one and two
year follow up of the SPIRT IV trial38,39 showed SES to have a reduction in lesion failure,
MI, and stent thrombosis compared to PES. When comparing Paclitaxel Eluting Balloons
(PEB) to PES, the BELLO randomized trial40 found that both treatment options had
similar rates of major adverse cardiac events with PEB having less lumen reduction at a 6
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month follow up. A scenario where balloon angioplasty and drug eluting balloons may be
preferred over stenting occurs during restenosis cases. Re-stenting vessels where
restenosis has occurred adds an additional stent layer to the vessels. This brings up
concerns for potential long-term effects of having multiple stent layers present in a
coronary vessel. In a short-term follow up, re-stenting with PES was shown to be superior
in addressing restenosis compared to balloon angioplasty. However, PES was not shown
to be superior in addressing restenosis compared to PEB in a short-term follow up.41 This
offers promising results for concerns with long-term use of multiple stent layers. The
option to use balloons, stents, and drugs with PCI, in addition to being complimentary
with angiography, makes PCI the optimal treatment to restore perfusion in the
myocardium.

Figure 6: Percutaneous Coronary Intervention (PCI). A catheter is guided into place
at the site of the blood clot. On the left the catheter is equipped with a balloon and is
performing balloon angioplasty. On the right the catheter is also equipped with a stent to
leave behind after expansion. Image courtesy of myheart.com
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1.2.4 Heart Transplantation
Once MI progresses to CHF, patients become candidates for more invasive
therapies including heart transplantation. Since 1967, after the first heart transplant, heart
transplantation has become the golden standard for treating patients with end-stage heart
disease.42 Heart transplantation requires a recently deceased allogeneic donor’s heart to
be transplanted into the patient. Due to complications with immune rejection, the donor
and the recipient must undergo extensive screening to ensure they are compatible.
However, even if the donor and patient are a good match, immune rejection is still a
major concern. Following transplantation, patients are required to take
immunosuppressive drugs for the remainder of their lives. Even with these precautions,
the 1-year and 5-year survival rates following heart transplantation are 81% and 69%
respectively.42
However, heart transplantation is not the ideal long-term treatment method. Due
to a severe lack of donors, heart transplantation is not capable of matching the
outstanding need for treatment. As of December 15th, 2017, 2977 heart transplants were
performed in 2017 with 3938 candidates still remaining on wait list.2 Even though heart
transplantation has the highest survival rates out of treatment options for patients with
end-stage heart disease, heart transplantation cannot be relied on as the sole treatment
option with such as severe lack of donors.

1.2.5 Left Ventricular Assist Device (LVAD)
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Left ventricular assist device (LVAD) implantation has been explored for a
‘bridge to recovery’, ‘bridge to transplantation’, and ‘destination therapy’ for patients
with MI. In these procedures LVADs are implanted to pump blood from the defective left
ventricle back into circulation through the aorta. In the severe cases, early implantation of
a LVAD is used as a ‘bridge to recovery’.
When cardiac shock becomes prevalent, clinical studies have explored implanting
LVADs as early as 0 to 14 days after MI as opposed to waiting until near organ failure.43.
By alleviating work load from the myocardium, more optimal myocardial recovery can
occur and potentially eliminate the need for a heart transplantation.44 Early LVAD
implantation has been ruled out in the past because of a feared increase risk of mortality
and the possibility of left ventricular recovery without surgical intervention.43 While on
the contrary, delaying LVAD implantation may lead to less favorable outcomes because
more time is allowed for progression towards congestive heart failure. Interestingly, one
clinical study by Chen (1999) has suggested patients may have similar results regardless
of late or early LVAD implantation following MI.43 These findings suggests the balance
between the advantages and disadvantages of early versus delayed LVAD implantation
may negate one another except for extreme cases.
As mentioned previously, heart transplant is a treatment method incapable of
matching the need for transplantation due to a severe lack of donor hearts. One possible
method for improving this situation is to keep the patients alive long enough to find a
suitable donor. This method is known as ‘bridge to transplantation’. A LVAD is
implanted onto the patient’s heart to help support life for the remainder of their life or
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until a suitable donor heart is found. One multicenter trial found the success rate of using
LVADs as a ‘bridge to transplantation’ to be 82% 154 days following LVAD
implantation. During this trial, 39.4% of patients received a heart transplant and 42.4% of
patients continued to remain on the waitlist.45
LVADs have also been explored as a ‘destination therapy’. Due to the lack of
treatment options for patients with end-stage heart disease, LVADs can be used as an
alternative to heart transplantation rather than a bridge to transplantation. In this scenario,
LVADs are implanted without the intention of performing a heart transplant in the future.
A follow up to the REMATCH46 clinical trial explored the survival rates of patients who
underwent LVAD implantation for ‘destination therapy’. Their results showed 86.1%,
56.0%, 30.9%, and 17.2% of patients were alive after the 30 day, 1 year, 2 year, and 3
year bench marks respectively.46
LVADs provide an alternative to patients in need of a heart transplant and have
shown to be beneficial following implantation. However, the survival rates for LVADs
do not match the survival rates for heart transplantation. Until there are readily available
treatment options with higher survival rates, there is still room for improvement in
treatment methods for patients with end-stage heart disease.
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Figure 7: Left Ventricular Assist Device (LVAD). A LVAD is implanted and attached
to a patient’s heart. Blood is pumped from the left ventricle to the aorta. An external
power supply and system controller are always worn by the patient.47

1.3 Cardiovascular Tissue Engineering
1.3.1 Introduction to Cardiovascular Tissue Engineering
Tissue engineering is a growing field offering promising avenues for new
treatment options for MI and CHF. Different approaches for tissue engineering explore
utilizing cellular therapy, hydrogels, and developing living functional non-thrombogenic
cardiac tissue. These approaches serve to either repair or replace damaged myocardium
without eliciting an immune response.
Current research has had limited success towards implementing these tissue
engineering approaches. Stem cells and hydrogels have been used separately and together
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to repair damaged myocardium. However, cellular retention has been a key issue
diminishing the potential for restoring cardiac function.
Engineering cardiac tissue for replacing or repairing the damaged myocardium
has been developed by combining cardiac linage cells with a compatible scaffold.
However, the desired cardiac properties and function has yet to be attained with
engineered cardiac tissue. Finding the optimal scaffold and method for cellular
infiltration has been important factors contributing towards the limited success using this
technique. Much research has been put into exploring various materials and methods that
can be used to developed cardiac tissue. Scaffolds used in tissue engineering can be
grouped into three types: synthetic, naturally derived, and decellularized tissue.
Techniques used for developing cardiac tissue can be grouped into three routes.
The first route is using a non-scaffold based approach by organizing cells in three
dimensional aggregates. This technique relies on influencing cells to secrete their own
extracellular matrix (ECM) to serve as a scaffold. The second route is an acellular
scaffold based approach. By implanting an acellular scaffold into the patient, host cells
are relied upon to infiltrate, re-organize, degrade, and vascularize the scaffold. Lastly, the
third route, is combining a scaffold with stem/progenitor cells in vitro.48–52

1.3.2 Cellular Therapy
Stem cells and progenitor cells have been used as an experimental tissue
engineering approach for treating MI. The goal of cellular therapy is to regenerate the
affected area, prevent re-occlusion, and inhibit as much of the remodeling process as
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possible. The basic rationale behind this goal is the assumption that the stem cells or
progenitor cells have potential to repair the affected myocardial tissue. Several clinical
studies have shown a beneficial effect on left ventricular function through a significant
increase in left ventricular ejection fraction when using bone marrow stem cells (BMSCs)
administered within 1-7 days following PCI compared to PCI alone.25 Interestingly, some
studies have shown BMSCs administered later than 7 days following reperfusion
displayed better results for left ventricular ejection fraction improvement.25,53
Additionally, one pilot study, TOPCARE-AMI54, showed that there was no significant
difference between administering bone marrow-derived progenitor cells versus blood
derived progenitor cells for improving left ventricular function.
The major disadvantage of cellular therapy in treating MI, is the lack of cellular
adhesion and presence in the administered areas post-injection. Administration of stem
and progenitor cells leads to cellular migration to distal organs and tissue with less than
10% cellular retention at the injection site.25,55 To improve cellular retention, Lee (2011)
conducted an animal study on rats where human amniotic-fluid stem cells (hAFSCs) were
aggregated into 3-dimensional spheroids prior to injection. Cells were aggregated to
induce extracellular protein secretion with the rationale that the secreted proteins would
improve adhesion to the myocardium post-injection. Their results demonstrated a 19%
cellular retention increase 4 weeks’ post-injection coupled with improved cardiac
function and attenuated remodeling as compared to injection of dissociated hAFSCs.55
Developing new seeding techniques to improve cellular retention can maximize the
beneficial affects cellular therapy offers for MI. This can lead to more successful
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regenerative approaches for restoring function to a poorly functioning myocardium and
may become the optimal approach for treating MI post-reperfusion

1.3.3 Scaffolds in Tissue Engineering
Scaffolds can be developed using various materials. Each material has their own
unique advantages and disadvantages. Synthetic scaffolds are made using polymers such
as: polyurethane (PU), polycaprolactone (PCL), polylactide acid (PLA),
polyglicerolsebacate (PGS), polyglycolic acid (PGA), and others including their copolymers.48–52 These synthetic polymer based scaffolds offer the advantage of custom
designed properties such as: tensile strength, degradation rate, porosity, and elastic
modulus.49,50,52 However, synthetic scaffolds are unfamiliar to cells and may not mimic
the biological performance as naturally derived materials due to complications with host
tissue integration and persistent inflammation.50,56 Interestingly, Mukherjee (2011) tried
to compensate for this disadvantage by combining poly(L-latic acid)-co-poly(ɛ caprolactone) (PLACL) with collagen in an electrospun fibrous membrane.
PLACL/collagen biomaterial was shown to respond favorably with cardiomyocytes.
After 10 days of exposure to the biomaterial, the cardiomyocytes aligned along the
nanofibers of the membrane.57 McDevitt (2002), treated poly(lactic-co-glycolic acid)
(PLGA) with laminin by microcontact printing techniques. This made the
microenvironment of the PLGA scaffold more suitable for cells such that seeded
cardiomyocytes formed fibers similar to native tissue.58
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Naturally derived scaffolds are made through biological polymers including:
collagen, fibrin, chitosan, alginate, gelatin, hyaluronic acid and others.48–52 These
naturally occurring biomaterials present a more favorable environment for cellular
adhesion, proliferation, and differentiation. They also present the advantage of not
eliciting a host immune response post implantation. The disadvantage of naturally
derived scaffolds are poor physical and material properties.50 Additionally, the
composition and architecture of native tissues will not be an identical match to naturally
derived scaffolds. Due to these disadvantages, naturally derived scaffolds are often used
for repairing damaged myocardium in the form of hydrogels or used in combination with
synthetic materials for engineering new cardiac tissue.57,59
Decellularized scaffolds are created through utilizing detergents and physical
methods to strip native tissue of cells while preserving as much ECM as possible. These
acellular scaffolds offer the desired microenvironment, composition, and architecture
needed for tissue engineering.48,49 However, the disadvantage of decellularized scaffolds
is the loss of crucial structural proteins, growth factors, and potential distortion of the
architecture following the decellularization process.60 Producing the optimal
decellularized scaffold is achieved through finding the balance between eliminating
immunogenic cellular debris and preserving ECM components.51,60
Various tissues and organs have been decellularized and used in cardiac tissue
engineering. For example, Zhao (2010), used fragments of decellularized porcine small
intestine submucosa to create an injectable emulsion suspended in sterile saline. Rats
with MI were injected at the infarct region with the emulsion. The decellularized small
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intestine submucosa emulsion improved cardiac function and increased wall thickness.61
However, it has been demonstrated that each tissue and organ has its own unique
microenvironment.49 This suggest that using decellularized myocardium is the most
optimal decellularized scaffold for cardiac tissue engineering. Lu (2013) decellularized
mouse hearts and seeded multipotential cardiovascular progenitor cells derived from
human induced pluripotent stems cells through the aorta into the left ventricular cavity.
After providing periodic perfusion with cell medium and growth factors for 20 days, the
seeded multipotential cardiovascular progenitor cells differentiated into cardiac cell lines
and the heart began beating.62 Similarly, Ott (2008) decellularized rat hearts and seeded
neonatal cardiac cells through intramural injection. Following 8-28 days of perfusion
culture, the rat hearts began displaying contractile and electrical responses when subject
to stimulations.63

1.3.4 Hydrogels in Tissue Engineering
Hydrogels have been used in tissue engineering by themselves to provide
structural support for damaged myocardium or in combination with stem/progenitor cells
to provide attachment sites for seeded cells in addition to structural support. In fact,
studies have shown that incorporating certain hydrogels with cellular therapy can
increase cellular retention and survival.59 Hydrogels can be created using synthetic
materials such as PEG, naturally derived materials such as collagen, or tissue specific
materials such as decellularized porcine myocardial ECM.59,64 One of the advantages of
using naturally derived materials and decellularized tissue as hydrogels is they do not
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elicit an immune response. Dai (2005), injected collagen directly in the scar region of rats
induced with MI. The collagen did not trigger an immune response and improved left
ventricle stroke volume while preventing infarct expansion.65 Two other types of
naturally derived hydrogels that have been shown to be beneficial for preserving
myocardial function post-MI, with or without including cells, are fibrin glue and
chitosan.59 Christman (2004), injected fibrin glue into the infarct zone of rats induced
with MI. By itself, the fibrin glue, preserved wall thickness and cardiac function.66 Lu
(2009) administered temperature-responsive chitosan hydrogels mixed with mouse
embryonic stem cells by intramural injection into the infarct region of rat hearts.
Following administration, they found an increased cellular retention and improved heart
function.67 However, the two main limitations with fibrin glue, chitosan, and many other
naturally derived hydrogels are lack of tissue specific extracellular microenvironment and
incompatibility with minimally invasive delivery techniques.59,64,68
Synthetic materials used as hydrogels offer similar advantages as when used as
scaffolds in other tissue engineering approaches. Customizable traits such as porosity,
degradation, and mechanical stability can be altered to make a synthetic hydrogel with
desired properties.69 Interestingly, one synthetic material, poly(N-isopropylacrylamide)
(PNIPAAM), has the capability to undergo phase transitions in response to temperature
changes. At room temperature PNIPAAM is a liquid, however, at physiological
temperatures PNIPAAM phase changes into a gel.59 This improves clinical relevance
because thermosensitive hydrogels can be delivered mixed with growth factors and/or
cells without surgical intervention.
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The most promising hydrogels can be delivered minimally invasively and
improve or preserve cardiac function post-MI. Two hydrogels that have been shown to
have these capabilities are decellularized porcine myocardial extra cellular matrix and
alginate.59,64,68,70 The most promising of the two is decellularized porcine myocardial
ECM because it also presents the advantage of having a tissue specific extracellular
microenvironment.59,64,68 A tissue specific ECM offers a promising avenue for improving
hydrogel integration with host cells in the native myocardium and increasing cellular
retention when administered with cardiac lineage cells.

1.3.5 Cardiac Patch Approach
A tissue engineering approach for repairing, rather than replacing damaged
myocardium, is developing a cardiac patch. Cells are seeded onto patches of scaffold to
give a site for cellular adhesion, improve cell survival, and induce ECM secretion and
blood vessel formation.49,51 Once the patch is implanted onto the injured myocardium, the
patch provides mechanical support.49–51 Leor (2000), created beating cardiac patches by
seeding fetal rat cardiac cells on to cylindrical porous alginate scaffolds. Following 9
weeks of implantation onto myocardial scar regions of rats with MI, the cardiac patches
were shown to diminish LV dilation and limit cardiac function deterioration.71
Matsubayashi (2003), used poly(ɛ-caprolactone)-co-poly(L-lactide) to synthesize a
spongy scaffold and reinforced it with kitted poly-L-lactide fabric to create a PCLA
patch. Vascular smooth muscle cells (SMC) were seeded onto the PCLA patches and
cultured for 2 weeks to prepare for implantation. SMC seeded PCLA patches were
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implanted onto the infarct zone of rats with MI for 8 weeks. Following implantation,
SMC seeded PCLA patches were shown to attenuate LV dilation and systolic function
deterioration.72

Figure 8: Cardiac patch. Cardiac lineage cells are seeded onto a porous scaffold.
Seeded scaffold is cultured to allow cellular attachment, proliferation, and scaffold
remodeling. Afterwards, the cardiac patch is implanted over the damaged myocardium.
Image courtesy of ninithi.wordpress.com
Another technique used in developing cardiac patches is cell sheets. This nonscaffold based approach utilizes layers of cardiac linage cells over top of each other to
develop a patch that can be implanted over the injured myocardium. Each sheet of cells is
cultured on 2D surface detachable magnetic particles or polymers.49 After detachment,
cells retain their adhesion proteins, secreted ECM, and attachment to one another because
enzymatic digestion is not used.56 Using cell sheets to create cardiac patches eliminates
complications associated with biodegradable scaffolds, such as persistent host
inflammatory response, because the cells secrete their own scaffold.50
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Interestingly, Shimizu (2002) overlaid sheets of cardiomyocytes onto a collagen
membrane to create a pulsatile cardiac patch. Upon implanting into the dorsal
subcutaneous tissues of rats, the pulsatile cardiac patches showed similar features as
myocardial tissue. The cardiac patches displayed gap junctions, sarcomeres, and
desmosomes.73 However, the key disadvantage of using cell sheets to create cardiac
patches is lack of vascularization. Without the capability of forming blood vessels
throughout the layered cell sheets, the thickness of the patch will be limited to three cell
sheets or 80µm in thickness.51,74 Lack of oxygen and nutrient supply will induce cells to
undergo apoptosis once the thickness of the patch surpasses the maximum depth diffusion
can reach.51 To compensate for this, Shimizu (2006) implanted 3-layer cardiomyocyte
cell sheets on to rat hearts and waited for 1, 2, or 3 day intervals to implant additional 3layer cardiomyocyte cell sheets. They found that 3-day intervals allowed for too much
connective tissue buildup on the outside of the first 3-layer cardiomyocyte sheet for
electrical coupling and synchronized beating to occur with additional 3-layer
cardiomyocyte sheets. However, 1 and 2-day intervals allowed for microvessel network
formation to occur and additional 3-layer cardiomyocyte sheets could electrically couple
and beat in sync with the first implanted 3-layer cardiomyocyte sheet. After repeating this
technique for additional 3-layer cardiomyocyte sheets, they were able to stack 10 sheets
of triple-layer cardiac patches while avoiding ischemia between the 3-layer sheets.74
However, the obvious downside to this technique is the risk of infection using
polysurgery and repeating an invasive surgical technique 10 times to implant so many
sheets.
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1.3.6 Whole Heart Tissue Engineering
Whole heart tissue engineering has been explored using decellularized xenogeneic
myocardial ECM as scaffolds. One of the biggest challenges in tissue engineering a
whole heart is preventing the blood contact surface from initiating thrombosis. The
potential of cell-seeded myocardial scaffolds will be diminished without the formation of
a complete functional endothelium to line the ventricular cavities and coronary
vasculature.3,75 Much of the research into creating tissue engineered whole hearts have
been geared towards either creating beating cardiac muscle tissue with cardiomyocytes
and stem/progenitor cells or creating non-thrombogenic cardiac tissue with endothelial
cells and stem/progenitor cells.63,75–77 Ng (2011) decellularized mice hearts and injected
embryonic stem cells and human mesendodermal cells derived from human embryonic
stem cells through the aorta. Seeded hearts remained in static culture for 14 days until
they were subcutaneously implanted into severe combined immunodeficiency mice for 2,
4, and 6 weeks. Afterwards, the stem cells expressed cardiac-specific markers.78
Stem cell differentiation into cardiac lineage cells demonstrates the translation
capability of tissue engineering whole hearts from benchtop to clinical practice. To
recellularize a whole heart, cells will have to be harvested from the host to prevent
immune rejection upon implantation. Stem cells are the most readily available cells with
the least harvesting complications that can be extracted from a patient and grown to
populations large enough for recellularizing a decellularized scaffold.
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Additionally, one study by Crawford (2012) demonstrated the potential self-life of
decellularized myocardial scaffolds. Crawford and colleagues decellularized rat hearts
and cryopreserved them for 1 year. They tested the cytotoxicity after thawing and
conditioning the tissue. No change in cytotoxicity was found when compared to a control
suggesting the applicability of cryopreservation to lengthen the self-life of decellularized
scaffolds.79 In a clinical setting, this decreases the wait time associated with developing a
tissue engineered whole organ by eliminating the need for decellularizing fresh tissue
every time a patient undergoes treatment.

Figure 9: Transformation from native heart to tissue engineered whole heart.
Native myocardium is decellularized using chemical, enzymatic, and/or physical
treatments. Decellularized scaffold is seeded with autologous cardiac lineage cells to
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recellularize scaffold. Following recellularization, seeded scaffold becomes a functional
heart.80
To date tissue engineered whole hearts are still far from being able to function
adequately to support life. Seeding and culturing cells on a scaffold is not a viable
method for creating a functional tissue engineered whole heart. In attempts to further
develop engineered cardiac tissue, bioreactors have become a recognized method for
improving the properties of tissue engineered constructs.50 In general, bioreactors have
the capability of monitoring and controlling the oxygen, nutrients, growth factors and
biophysical stimuli present in the culture environment of the tissue.56 Bioreactors created
for heart muscle can provide a combination of mechanical and electrical stimuli to
improve function properties, ECM secretion by seeded cells, and homogeneity of the
tissue.56,81 Static, perfusion, rotating, and mixed/turbulent flow are four categories that
can be used to group bioreactors.81 Each category is associated with its own advantages
and disadvantages that are better suited for different types of tissue. However, not all of
them have been shown to induce enough diffusion to create a compact tissue with
uniformly distributed cell density.51 Perfusion bioreactors are shown to be the most
effective for conditioning geometrically complex tissues accustom to mechanical
constraints in vivo such as cardiac tissue.82
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Figure 10: Depiction of a bioreactor. Seeded myocardium is conditioned in a
bioreactor to improve cardiac functions and tissue properties. Image courtesy of
boston.com
In summary, there any many current treatment options for patients with MI. Some
treatment options focus on reperfusion following occlusion while others focus on
repairing or replacing the function of the myocardium during the healing phase of MI.
However, there does not exist an optimal treatment option that provides the desired
mortality rate without a lengthy wait period to receive treatment. Tissue engineering has
been a growing field which offers many avenues that may lead to new and improved
treatment options for MI and CHF. However, there is still much research that needs to be
accomplished before tissue engineering can offer a viable solution. Current tissue
engineering strategies have associated gaps in knowledge that are halting progress
towards achieving new or improved treatment methods. Complications associated with
current MI treatment options and the limited success with cardiovascular tissue
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engineering provides the need for research into new potential treatment methods for MI
and CHF.

1.4 Project Scope, Aims, and Significance
1.4.1 Project Scope
Across the world, over 7 million people are estimated to be affected by MI.17
Each year in the United States alone, around 900,000 people are diagnosed with MI.19
The pathological progression of MI goes from acute, to healing, to healed in the injured
region of myocardium.23 The consequences associated with this progression result in
elevated wall stresses and loading conditions. Altered mechanical stresses and the
formation of acellular scar tissue stimulates the onset of hypertrophy and dilation.24
Ultimately, the repercussions of MI may lead down a pathway towards congestive heart
failure (CHF).
Current treatment options for MI and CHF are not ideal. In the acute phase of MI,
reperfusion therapy is the primary treatment. Several reperfusion methods exist
including: coronary artery bypass grafting, fibrinolysis, thrombolysis, and percutaneous
coronary intervention. However, these treatment options solely focus on re-introducing
blood flow into the ischemic myocardium instead of repairing the damage caused by
ischemia. Treatment options for CHF and more severe cases of MI, such as left
ventricular assist device (LVAD) and heart transplantation, focus on replacing the
damaged myocardium versus healing it. LVADS are beneficial to patients but do not
produce survival rates sufficient for an ideal treatment option.45 While heart
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transplantation remains the golden standard for treating end stage heart diseases, the need
for treatment is vastly unmeet by the number of transplantations occurring each year.2
New treatment options are needed to improve survival rates of patients with CHF and
advanced stages of MI.
Tissue engineering is a growing field exploring new experimental treatment
methods for MI and CHF. However, the clinical success of these avenues has been
limited. The end goal of this research is to develop a tissue engineered whole heart
utilizing an acellular myocardial scaffold and the patient’s own cells. This tissue
engineered whole heart would then be used instead of an allogenic cadaveric heart during
heart transplantation. Utilizing this technique would present two advantages over
traditional heart transplants. One, the tissue engineered whole heart would not elicit an
adverse immune reaction because the patient’s own cells would be used to recellularize
the acellular scaffold. This would improve the patient’s quality of life posttransplantation surgery because the need for administering lifelong immunosuppressant
drugs would be eliminated. Second, the tissue engineered whole heart would be more
readily available than an allogenic cadaveric heart. The time between approval for
surgery and transplantation would be limited to the timespan required for harvesting the
patient’s cells, expanding the cells in culture, seeding the cells onto the off-the-shelf
acellular scaffold, and bioreactor conditioning of the tissue engineered whole heart.
One of the biggest challenges in cardiovascular tissue engineering is developing
an anti-thrombogenic surface.3 Previously, research into creating an anti-thrombogenic
surface to line the ventricles of decellularized whole hearts has been geared towards
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recreating an endothelium while neglecting the remaining layers of the
endocardium.63,75,76 However, the endocardium is essential to maintaining a healthy heart
and may play an integrate role in regulating cardiac function.12 The following research
discussed in this paper is focused on developing a reconstituted endocardium in the
ventricular cavities of acellular myocardium.

1.4.2 Project Aims
Aim 1: To develop and characterize an acellular rabbit myocardial scaffold through
bi-ventricular perfusion decellularization.
Hypothesis: Our bi-ventricular perfusion decellularization system will produce acellular
whole rabbit hearts with preserved ventricular cavity surface structure, shape, and
extracellular composition.
Aim 2: To reconstitute the endocardium inside the acellular ventricular cavities
with clinically relevant hydrogels and cell types.
Hypothesis: Our novel seeding device, technique, and bioreactor will support hydrogel
adherence and cellular attachment, integration, and activity on the surface of ventricular
cavities of acellular whole rabbit hearts.

1.4.3 Project Significance
We are the first researchers to pursue tissue engineering the endocardium, as
opposed to exploring re-endothelializing the endothelium, inside the ventricular cavities
of decellularized myocardium. This research will bring our laboratory closer to
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accomplishing a tissue engineered whole heart and hopefully enhance the scientific
communities understanding of the endocardium. The following information will shed
light on the interactions between hydrogels, cells, and acellular myocardial tissue.
Various seeding techniques were used demonstrating the applicability of combining
multiple techniques to develop optimal protocols for cell seeding. In general, it is our
hope that this project will aid in the advancement of the growing field of cardiovascular
tissue engineering and make progress towards the development of alternative treatment
options for MI and CHF.
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CHAPTER TWO
DECELLULARIZATION OF WHOLE HEARTS

2.1 Introduction
One of the most promising avenues for developing a tissue engineered whole
heart for transplantation is combining stem/progenitor cells with a decellularized
myocardial scaffold. Decellularized myocardial scaffolds are created by stripping native
cells from their adhesion sites while preserving the structure and composition of the
ECM. Using decellularized myocardium as a scaffold for cardiac tissue engineering
presents several advantages. First, the vasculature pathways are preserved providing the
frame work for creating blood vessels to supply nutrients to seeded stem/progenitor cells.
One of the biggest challenges in cardiovascular tissue engineering is developing a nonthrombogenic blood vessel or blood vessel substitute.83 This is especially true for tissue
engineering whole organs. Similar to the limitation for cell sheeting, there is a depth limit
for how far cells can be seeded into a scaffold and still remain viable. Once diffusion can
no longer mediate nutrient exchange, it becomes apparent that a blood vessel or blood
vessel substitute is needed to reach the seeded cells. Second, decellularization effectively
eliminates all immune reacting agents. This allows for the scaffold to be implanted in the
body without eliciting an adverse immune response like naturally derived and
biodegradable synthetic materials. However unlike decellularized myocardium or
naturally derived materials, biodegradable synthetic scaffolds may emit degradation
products that cause persistent host inflammation.50 Lastly, decellularized myocardium
presents a unique set of structural advantages by having a microenvironment,
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composition, and architecture that resembles native myocardium.48,49 Additionally, the
preserved architecture provides adhesion sites previously occupied by native cardiac cells
for attaching seeded stem/progenitor cells. This tissue specific microenvironment has yet
to be recreated using naturally derived or synthetic materials. However, effectively
decellularizing whole organs without compromising ECM integrity is a difficult task.
Some researchers have reported the loss of growth factors, ECM proteins, and distortion
of scaffold architecture while using certain decellularization protocols.60
The first successful decellularization of a whole heart was reported by Ott (2008).
They accomplished perfusion decellularization of whole rat hearts.63 Since then, many
researchers have reported the successful decellularization of whole hearts from several
species.62,75–79,84–90 Each species has varying clinical relevance and practical justification.
In our study, we choose to decellularize whole rabbit hearts. Although rabbit hearts are
not as clinically relevant in size as porcine or cadaveric human hearts, they are more
clinically relevant than mouse and rat hearts. Rabbit hearts come from a live source
limiting the potential disease state that may be present unlike cadaveric human hearts.
Less resources are required to decellularize and recellularize rabbit hearts making them
more cost-effective than cadaveric human hearts or porcine hearts. Lastly, the
decellularization system adapted from Jason Schulte is limited to housing only one
cadaveric human heart or one porcine heart cannulated at the aorta. We successfully
modified the inner-housing chamber design to fit four bi-ventricular cannulated rabbit
hearts. This allowed us to generate a large number of replicates for statistical comparison
while effectively decellularizing both ventricles.
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2.2 Methods
2.2.1 Whole Heart Collection and Preparation
Rabbits were beheaded, skinned, and shipped frozen on dry ice for 48 hours from
Animal Technologies (Tyler, TX) (Figure 11A). Following euthanasia, the use of
harvested tissue from an animal carcass is not covered by IACUC. Once the rabbit
carcasses arrive, they are stored in a -20˚C freezer until tissue dissection. Prior to tissue
harvesting, rabbit carcasses are thawed for 5 hours on bench top. Whole hearts are
extracted from rabbit carcasses with careful consideration to not puncher or damage any
of the heart’s chambers. Ample length of pulmonary trunk, aorta, inferior vena cava,
superior vena cava, and pulmonary veins and arteries are left intact for cannulation or
ligation. Rabbit hearts underwent three cycles of submerging and gently massaging in 30
mM Ethylenediaminetetraacetic Acid (EDTA) to remove potential blood clots inside the
ventricles. After washing, rabbit hearts were stored in a -20˚C freezer until the first day of
decellularization.
To prepare rabbit hearts for attachment to our decellularization system, each of
the four rabbit hearts were cannulated at their aortas and the pulmonary trunks with
barbed lures. Sutures wrapped tightly around the vessels reinforced by zip-ties secured
the barbed lures in place. All other vessels attached to the heart were ligated by bundling
them together and tightly lassoing a suture around them (Figure 11B).
To acquire fresh native heart samples for a control in immunohistochemistry, a
native rabbit heart was dissected from a fresh rabbit carcass shipped from Animal
Technologies. The rabbit was beheaded, skinned and shipped overnight on ice. Once the
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carcass arrived, the heart was immediately dissected from the thoracic cavity. Following
dissection, the fresh native rabbit heart was submerged and massaged in Phosphate
Buffered Saline (PBS) three times to remove excess blood in the chambers and
vasculature. Fresh PBS was used all three times. We used 10% buffered formalin to store
the fresh native rabbit heart after rinsing with PBS. The fresh native rabbit heart was left
static in the 10% buffered formalin for 4 days until samples were acquired for
immunohistochemistry.
For histology and scanning electron microscopy, a fresh native rabbit heart was
retrieved from the Godley Snell Research facility in Clemson, SC following the
euthanasia of a control group of rabbits from an unrelated animal study. Rabbit hearts
were dissected at the facility following rabbit euthanasia and stored in 10% buffered
formalin. After 4 days of fixation, we collected samples from the fresh native rabbit
heart.

2.2.2 Decellularization System Set-Up
The Decellularization System was originally adapted by Jessica Canavan from Dr.
Schulte’s decellularization protocol for porcine myocardium.90,91 However, Jessica
Canavan’s rabbit heart tree composed of numerous y-connectors and small diameter
tubing has since been replaced with a circular glass manifold supported by a 3-D printed
ABS stand (Figure 12). Currently, the decellularization system is composed of an acrylic
housing chamber, two fluid reservoirs, a glass manifold, a 3-D printed ABS stand, and a
multi-channel peristaltic pump (Masterflex, Cole-Parmer) (Figure 13). The circular glass
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manifold attaches four hearts with ¼ inch inner diameter tubes at the pulmonary trunk
and aorta to allow retrograde perfusion into each ventricle. The acrylic housing chamber
and both fluid reservoirs are connected in series by ¼ inch inner diameter tubes. The first
fluid reservoir was positioned 90 cm above the cannulated rabbit hearts. Gravity drives
each decellularization solution down from the first reservoir into the circular glass
manifold located inside the acrylic housing chamber. The hydrostatic pressure generated
from this height difference yielded a pressure of 12.72 mmHg entering each ventricle.
The second fluid reservoir was positioned below the acrylic housing chamber at an
unspecified distance. The multi-channel peristaltic pump was located below the second
fluid reservoir at an arbitrary distance from the second fluid reservoir. Gravity drives
each decellularization solution from the acrylic housing chamber to the second fluid
reservoir and from the second fluid reservoir to the multi-channel peristaltic pump. Fluid
is driven upward from the multi-channel peristaltic pump back to the first fluid reservoir,
where the process repeats itself. For every decellularization solution, 3.5L was used in the
decellularization system.

2.2.3 Decellularization Procedure
Decellularization began by perfusing 30mM EDTA in PBS (pH 7.5) into each
rabbit heart ventricle via the decellularization system to remove potential blood clots. The
following day the solution was replaced with 1% w/v Sodium Dodecyl Sulfate (SDS) to
begin removing cellular and DNA content. SDS treatment continued for a total of 20 days
with fresh 1% w/v SDS replaced every 4 days. Afterwards, we began a series of wash
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cycles with every cycle consisting of three fresh solution changes occurring at increments
of 4 hours, overnight, and 4 hours. For the first wash cycle we used ddi water, followed
by 70% ethanol for the second cycle, ddi water for the third cycle, and PBS for the final
cycle. At the conclusion of the wash cycles, we replaced the last solution with 720
milliunits RNAse/DNAse in PBS with 5mM MgCl2 (pH 7.4). RNase/DNase treatment
continued for 4 days with fresh solution replaced at the 2-day mark. Lastly, we began a
final wash cycle of PBS following RNAse/DNase treatment. The PBS wash cycle was
conducted analogous to previous wash cycles where fresh solution was replaced in
increments of 4 hours, overnight, and 4 hours. Every solution perfused overnight
included 0.02% sodium azide for sterility. Once the decellularization procedure was
complete, each decellularized scaffold was removed from the circular glass manifold and
stored at 4˚C in a PBS cocktail containing 0.02% sodium azide and 0.001% protease
inhibitor.

2.2.4 DNA Extraction and Quantification
Native tissue was used a control for all DNA quantification. DNA was extracted
from decellularized tissue (n=6) and native tissue (n=6) using a DNeasy® Blood &
Tissue Kit from Qiagen (Hilden, Germany). Samples were quantified using nanodrop
spectrometry with a reading absorbance of 260 nm. Each quantified sample was
normalized using the respective sample wet weight measured prior to tissue digestion.
Normalized quantities were displayed as ng/mg wet tissue.
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Additionally, ethidium bromide agarose gel electrophoresis was used on DNA
isolated native tissue samples (n=6) and decellularized tissue samples (n=6) for analysis.
DNA bands were obtained using Sub-Cell® GT electrophoresis protocol and equipment
(170-4402, BioRad, Hercules, CA) and measured in a BioRad Gel Imager using
densitometry.

2.2.5 Histology and Immunohistochemistry (IHC)
Following formalin fixation, decellularized scaffold and fresh native rabbit hearts
were used for sample collection. Rectangular sections along the circumferential axis were
obtained from both ventricles and horizontal rectangular sections were obtained from the
septum wall. An automated Sakura Tissue Tek VIP 5 Tissue Processor (2315-30-1003,
Sakura, Torrance, CA) was used to process samples and prepare them for paraffin
embedding. The automated process consisted of a series of steps where samples undergo
10% buffered formalin washes, incremental dehydration from 70% ethanol to 100%
ethanol, xylene incubation, and paraffin incubation. Upon sample retrieval from the tissue
processor, samples were embedded in paraffin and sectioned using at microtome to
produce 5 µm sections on glass histological and IHC slides.
For histology, sections adhered to glass histological slides were rehydrated and
stained for either Masson’s Trichrome for Connective Tissue or Diamidino-2phenylindole (DAPI) fluorescent nuclear stain. Masson’s Trichrome for Connective
Tissue stain was conducted using the provided staining kit and protocol (k037, Poly
Scientific R&D Corporation, Bay Shore, NY). DAPI fluorescent nuclear stain was
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performed using a special mounting medium containing DAPI (H-1500, Vector
Laboratories, Burlingame, CA).
IHC began with rehydrating sections adhered to glass IHC slides. Following
rehydration, antigen retrieval was accomplished by 10-minute exposure to 90˚C 10mM
citric acid monohydrate (pH 6). Afterwards, IHC slides were treated with 0.025% Triton
X-100 in two 5-minute increments. Next, IHC slides were incubated with normal
blocking serum for 45 minutes before primary antibody administration. Mouse AntiLaminin (MAB1922; Millipore, Burlington, MA), Mouse Anti-Fibronectin (MAB1940;
Millipore), and Mouse Anti-Collagen IV (Dako Agilent Pathology Solutions, Santa
Clara, CA) primary antibodies were applied in dilutions of 1:500, 1:300, and 1:33
respectively for either an overnight incubation in a 4˚C incubation chamber or a 1-hour
incubation at room temperature. To obtain a negative control per IHC slide, the primary
antibody was omitted in one of the sections. The diaminobenzidine tetrahydrochloride
peroxidase substrate kit and R.T.U. Vectastain Kit were purchased from Vector
Laboratories. To counterstain IHC slides, hematoxylin diluted in distilled water was
applied for 40 seconds. Following dehydration and mounting, Zeiss Axiovert 40CFL
microscope and AxioVision Release 4.6.3 digital maging software (Carl Zeiss
MicroImaging, Inc., Thornwood, NY) were used to image all histological and IHC stains.

2.2.6 Scanning Electron Microscopy (SEM)
Decellularized scaffold samples and fresh native samples fixed in 10% buffered
formalin were washed with ddH20 for 30 minutes with fresh ddH20 replaced every 10
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minutes. Samples were treated with 1% osmium tetroxide for 1 hour to accomplish
secondary fixation. Following secondary fixation, another wash with ddH20 lasted for 30
minutes with fresh ddH20 replaced every 10 minutes. Increasing increments of ethanol
from 50% to 100% was used to dehydrate samples. After dehydration, samples were
dried using hexamethyldisilazane (HMDS) by treating them with 50/50 ethanol/HMDS
for 15 minutes, pure HMDS for 15 minutes, and left overnight setting in pure HMDS. A
platinum coating was applied to tissue samples and imaged using Hitachi S4800 SEM at
Clemson University Advanced Materials and Research Facility, Anderson, SC.

2.2.7 Statistics
Data obtained from nanodrop spectrometry was quantified by reading absorbance
and normalized by wet weight for analysis using a student t-test.

2.3 Results
The novelty of this decellularization system (Figure 13) is that it houses 4 rabbit
hearts while perfusing decellularization chemicals into both ventricles simultaneously
(Figure 12). We utilized multiple techniques to analyze the effectiveness of cellular
removal using this system. First, the color change of burgundy in fresh native tissue to
snow-white in decellularized tissue suggested successful decellularization (Figure 14).
Second, DNA analysis using nanodrop spectrometry revealed a significant drop in DNA
content from native tissue to decellularized tissue. Additionally, gel electrophoresis
depicted a lack of DNA content in decellularized tissue samples (Figure 15). Third,
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DAPI fluorescent nuclear stain and Masson’s Trichrome stain did not stain positive for
nuclei in decellularized tissue samples (Figure 16). Fourth, SEM images of the
decellularized scaffold did not reveal an endothelium on the surface of the tissue (Figure
18) IHC stained for basal lamina components (laminin, collagen IV, and fibronectin) was
performed for decellularized samples and native samples (Figure 17). Lack of positive
stained regions in collagen IV and fibronectin IHC stains suggests the decellularization
procedure caused partial disruption of the basal lamina.
Rabbit Heart Preparation

A

B

Figure 11: Tissue collection. (A) Rabbit carcass delivered from Animal Technologies.
Carcass is thawed in glass tray on bench top prior to dissection. (B) Four rabbit hearts
cannulated at the aorta and pulmonary trunk prior to decellularization. All other entering
and exiting vessels are bundled together and ligated.
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Manifold and Stand Design

B

A

Figure 12: Decellularization manifold and stand. (A) Solidworks designs showing
manifold and stand. (B) Representative image of decellularization fluid flowing into both
ventricles of four rabbit hearts attached to the manifold.
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Decellularization System

1

2

3

2

1
4

Figure 13: Rabbit heart decellularization system. Decellularization system composed
of, 1, two fluid reservoirs, 2, two overflow containers for reservoirs, 3, circular glass
manifold and 3-D printed ABS stand stored inside an acrylic housing chamber, 4, multichannel peristaltic pump.
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Fresh Native Heart

Decellularized Heart

A

B

Figure 14: Decellularization cue by color change. Fresh native heart changes from (A)
burgundy to (B) snow-white during decellularization.
Nanodrop Spectrometry

Gel Electrophoresis

A

B

Figure 15: DNA analysis of native rabbit heart and decellularized scaffold. (A)
Averaged DNA content from Decellularized scaffold samples and fresh native rabbit
heart samples obtained from nanodrop spectrometry. (B) Isolated and digested DNA
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content from decellularized scaffold and fresh native samples assessed using gel
electrophoresis. From left to right the columns are: blank, standard, fresh native samples
1-6, and decellularized scaffold samples 1-6.

Figure 16: Histological analysis of native rabbit heart and decellularized scaffold.
(A) DAPI fluorescent nuclear stain and (B) Masson’s Trichrome stain on native rabbit
myocardium and decellularized scaffold. Bars are set to 100 µm.
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Figure 17: Immunohistochemistry analysis of native rabbit heart and decellularized
scaffold. IHC on basal lamina components: (A) Collagen IV, (B) Fibronectin, and (C)
Laminin. Positive reactions depicted by black arrows. Negative controls displayed in
bottom corner of each image. Bars are set to 50 µm.

Figure 18: Scanning Electron Microscopy (SEM) analysis of native rabbit heart and
decellularized scaffold. (A) Left ventricle and (R) right ventricle samples were imaged
at 200x magnification and 1000x magnification.
2.4 Discussion
2.4.1 Decellularization Indicated by Color Change
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Images of rabbit heart before and after decellularization are shown in Figure 14.
First, a picture was taken of fresh native rabbit heart prior to vessel cannulation and
ligation. Then another picture was taken following the conclusion of decellularization.
Through the decellularization process, the color of each rabbit heart progressively
changed from burgundy to white indicating the removal of cellular content. Ott (2008)
described a similar change in color during decellularization of rat hearts. Retrograde
perfusion of SDS through the aorta of the rat hearts was performed for 12 hours.
Afterwards, they reported a chamber by chamber change in color. First, both atria turned
translucent, followed by the right ventricle, and ending with the left ventricle.63 In our
study we used retrograde perfusion into both ventricles through the aorta and the
pulmonary trunk (Figure 12B). However, we did not keep track of the chamber by
chamber change of color through the progression of our decellularization procedure. We
also used hearts from a larger species and decellularized multiple hearts at once,
accounting for the longer duration and larger number of SDS cycles.

2.4.2 Decellularization Indicated by DNA Reduction
DNA content was assessed using nanodrop spectrometry and gel electrophoresis
(Figure 15). Gel electrophoresis did not reveal any white bands in the decellularized
scaffold sample columns, while white bands can be seen in both the standard and fresh
native sample columns. White bands appearing in the sample columns are an indication
of DNA content present in those samples. The lack of white bands found in the
decellularized sample columns suggests the successful removal of DNA content.
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A student’s t-test on quantified DNA content from decellularized scaffold samples
and fresh native myocardium samples revealed a significant reduction in DNA content
(p-value < 0.001). DNA concentration was reduced by 85.7% from 664.5 ± 128.4 ng
DNA/mg tissue for fresh native myocardium to 95.1 ± 8.6 ng DNA/mg tissue for
decellularized scaffold. Zhang (2015) also reported the successful decellularization of
rabbit hearts. New Zealand white rabbit hearts were decellularized using antegrade
perfusion of SDS for 12 hours per heart. They saw a DNA reduction from 513.6 ± 16.9
ng DNA/mg tissue to 48.3 ± 13.4 for native myocardium to decellularized myocardium.89
Although they reported a higher reduction in DNA concentration, we had a larger
standard deviation associated with our quantification of native DNA content which may
be skewing our results. More native samples will be needed to gain a more accurate
representation of the DNA content found in the rabbit hearts we used for
decellularization.

2.4.3 Decellularization Assessment by Histology, SEM, and IHC
Fresh native myocardium and decellularized scaffold samples were stained with
DAPI fluorescent nuclear stain and Masson’s Trichrome stain for connective tissue
(Figure 16). DAPI fluorescent nuclear stain did not reveal any remaining nuclei in the
decellularized scaffold samples while a cell dense myocardium could be seen in the fresh
native samples. Lack of fluorescing nuclei indicates the elimination of cells in the
scaffold during decellularization. Masson’s Trichrome stain depicts collagen as blue,
muscle fibers as red, and cells as black. In the fresh native samples, Masson’s Trichrome
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stain revealed a dense muscle fiber environment encased in a collagen network with cells
dispersed throughout the sample. Decellularized scaffold samples stained with Masson’s
Trichrome stain displayed a different environment. Nuclei was not present evident by
lack of black positive stained cells. Majority of the remaining scaffold was composed of
collagen. Muscle fibers content was mostly eliminated with only a few regions faintly
stained red. The structure, collagen fiber orientation, and extracellular matrix architecture
of the decellularized scaffold was kept mostly intact. Additionally, the decellularized
scaffold had a larger number of pores with various open compartments previously
occupied by cells.
Others have also used these histological stains to examine decellularized
scaffolds. Weymann (2011, 2014) used DAPI fluorescent nuclear stain and Masson’s
Trichrome to evaluate porcine heart scaffolds decellularized with SDS. They discovered a
lack of nuclei depicted from DAPI fluorescent nuclear stain and verified the preservation
of the extracellular matrix using Masson’s Trichrome.76,92 Perea-Gil (2015) used
Masson’s Trichrome on porcine heart scaffolds decellularized by either SDS or
hypertonic and hypotonic solutions. Masson’s Trichrome stain revealed a lack of positive
black stained cells in the scaffolds decellularized by both procedures, indicating the
removal of cellular content.84
SEM images at low magnification (200x) and high magnification (1000x) of the
endocardium of decellularized tissue did not reveal an endothelial monolayer (Figure
18). Both ventricles of the decellularized scaffold retained similar surface structures and
shape as native ventricles. Low magnification images revealed ridges of collagen
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bundles. High magnification images depicted several regions with a confluent surface
rich in available bonding sites. Other researchers have also used SEM to verify the
removal of cellular content of decellularized heart scaffolds. Ott (2008) reported the
removal of myofibrils in the myocardium using SEM following decellularization of rat
hearts with SDS.63 Similarly, Carvalho (2012) decellularized rat hearts with SDS and
used SEM to verify the removal of cellular content and preservation of the extracellular
matrix.86
The use of detergents to decellularize tissues has been reported to remove or
disrupt essential extracellular matrix components in literature.60 SDS alone has been
shown to disrupt collagen integrity and diminish glycosaminoglycan content while
effectively removing cellular components.93 Every component of the extracellular matrix
is crucial for maintaining a heart scaffold that mimics the native cardiac environment.
IHC stains were conducted on the basal lamina components to assess the potential impact
of our decellularization procedure on the basal lamina composition. We choose to assess
the basal lamina of the scaffold’s ventricles because the basal lamina is responsible for
attaching endothelial cells to the endocardium in native cardiac tissue. Collagen IV,
fibronectin, and laminin are three basal lamina proteins that were chosen for evaluation
(Figure 17). Our decellularized scaffold did not stain positive for collagen IV and
fibronectin proteins during IHC staining. The lack of these proteins suggested the basal
lamina is disrupted during decellularization. However, lamina stained positive on our
decellularized scaffold implying the basal lamina was only partially disrupted.
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2.5 Conclusion
Previous literature reports have used DNA quantification, histology, SEM, and
color change to evaluate decellularization. Based on these reports, our methods are
sufficient to assess the effectiveness of our decellularization procedure. Although our
DNA quantification with nanodrop spectrometry only revealed an 85.7% decrease in
DNA content, the combination of our other results revealed our decellularization
procedure effectively eliminated cellular content. However, we also discovered our
decellularization procedure had a negative impact on the basal lamina. Our IHC stains
suggest the removal of collagen IV and fibronectin occurred along with the removal of
cellular and DNA content. Despite this disadvantage, we determined the decellularization
procedure yielded an acellular scaffold compatible with cell seeding.
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CHAPTER THREE
RECONSITUTION OF THE VENTRICULAR ENDOCARDIUM WITHIN
ACELLULAR SCAFFOLDS

3.1 Introduction
3.1.1 Background and Significance
One of the biggest challenges in cardiac tissue engineering is developing an antithrombogenic blood contacting surface for engineered tissue. Without an antithrombogenic surface, the intrinsic coagulation cascade will be activated. This pathway
will eventually lead to thrombosis and cause life endangering complications. In vivo, a
tightly sealed endothelial monolayer covers the entire blood contacting surface of all
cardiac tissue and vasculature. The endothelium acts to actively prevent thrombosis and
allow nutrients and gas exchange to occur in between the gap junctions of the endothelial
cells.
Many researchers have attempted to recreate a monolayer of endothelial cells on
decellularized cardiac scaffolds with limited success.63,75,76 This is an effective method to
recreate an anti-thrombogenic surface for vasculature, however, the inner lining of the
ventricular wall of cardiac tissue is more intricate than an endothelium. The endothelium
is part of the multilayered endocardium. As previously mentioned, the endocardium has
pathological consequences in the presence of many cardiac diseases and may have
several impactful functions in cardiac performance.12–16 This makes the endocardium a
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crucial component necessary to develop a tissue engineered whole heart. To our
knowledge we are the first researchers to explore reconstituting the endocardium in
acellular heart scaffolds.
In addition to reconstituting the endocardium, we also explored recellularizing the
endothelium of the coronary vasculature. To tissue engineer a whole heart, eventually
every component of the heart’s structure must be recellularized and reconstituted. The
significance in recreating the endothelium in the coronary vasculature is developing a
network of a pathways for delivering nutrients and providing gas exchange. Currently,
one of the biggest challenges in cardiac tissue engineering is developing vasculature for
tissue engineered constructs.80 Similar to how the maximum thickness of cell sheeting
cannot exceed 80µm due to the depth of nutrients and oxygen diffusion, the layers of a
reconstituted heart wall cannot cumulatively exceed 80µm without a means to supply
nutrients and gas exchange to the inner regions.51,73 Because the average thickness of the
human ventricular endocardium does not exceed 20µm, it is not imperative to have a
network of vasculature for the goal of this project.13 However, in future experiments if
recreating the endocardium of the atria is explored, then it will be necessary to have a
network of vasculature to keep the endocardium viable for thicknesses greater than
80µm.

3.1.2 Overview of Experimental Procedural Evolution
Several experiments were performed on decellularized scaffold. Three
experiments were performed for seeding human aortic endothelial cells (hAOECs) into
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the ventricular cavities of decellularized scaffolds. Each of these experiments aimed at
assessing the feasibility of recellularizing the endocardium using either static or
centrifugal seeding techniques for administering cells. The first endocardium seeding
experiment utilized static seeding. While the last two endocardium seeding experiments
were duplicates of one another to assess the feasibility of centrifugal seeding.
Two experiments were performed for seeding endothelial cells into the coronary
vasculature using a gravitational seeding technique. The second coronary seeding
experiment was performed to verify reproduceable results of the first coronary seeding
experiment. After attempting coronary vasculature and endocardium recellularization, we
decided to focus on improving endocardium cell seeding.
We attempted two hydrogel experiments to gauge the feasibility of using different
techniques for influencing collagen and fibrin hydrogels to infiltrate into the ventricular
surface of our decellularized scaffold. The first hydrogel experiment explored
lyophilization and static infusion as a potential route for integrating hydrogels into the
scaffold. The second hydrogel experiment assessed a sequence of gravitational,
centrifugal, and rotational infusion techniques as a potential route for integrating
hydrogels into the scaffold. Afterwards, we decided to move forward with incorporating
collagen and fibrin hydrogels infused by a combination of techniques into
recellularization experiments focused on the endocardium.
Three experiments were geared towards reconstituting the endocardium using a
combination of hydrogels and cells. All three experiments included gravitational,
centrifugal, and rotational cell seeding and hydrogel infusing techniques. The first
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experiment integrated a mixed collagen-fibrin hydrogel into the ventricular cavities
followed by seeding a layer of hAOECs and human adipose-tissue derived stem cells
(hADSCs, LaCell Inc, New Orleans, LA). The last two experiments utilized a layer-bylayer tissue engineering approach for reconstituting the endocardium. The third
endocardium reconstitution experiment did not fill in any missing information for this
thesis and will be used to show reproducibility for a later publication. The results from
third endocardium reconstitution experiment will be left out of this thesis and be finished
a later date. In the second and third endocardium reconstitution experiments, collagen and
fibrin hydrogels were infused separately along with layers of fibroblast cells
differentiated from adipose derived stem cells and endothelial cells. A summary of each
experiment’s methods, rationale, and outcomes can be found in Table 1.

3.2 Methods
3.2.1 Scaffold Preparation for Recellularization and Reconstitution Experiments
Each of the three endocardium seeding experiments, two coronary seeding
experiments, and three endocardium reconstitution experiments began with the same
scaffold preparations. First, the scaffold was checked for non-sutured holes or vessels
unbound by ligation. Any holes or unbound vessels were sutured closed except for the
aorta and pulmonary trunk. Sterile 0.1% peracetic acid was made in ddH20 and pH to
7.4. The scaffold was incubated in 100 mL of sterile 0.1% peracetic acid at room
temperature for 2 hours to sterilize the tissue. Sterile 1xPBS was made in ddH20 and pH
to 7.4. Following sterilization, the scaffold was washed with 100 mL 1xPBS for three
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hours at room temperature. Sterile 1xPBS was replaced after every hour for a total of 3
fresh solution changes. A sterile cocktail containing half Fetal Bovine Serum (FBS)
(Atlanta Biologicals, Flowery Branch, GA) and half Dulbecco’s Modified Eagle Medium
(DMEM) (ThermoFisher Scientific, Waltham, MA) was made. After sterile 1xPBS
washes, the scaffold was placed into 100 mL of sterile 50/50 FBS/DMEM and incubated
at 37˚C overnight. Following overnight incubation, the sterile 50/50 FBS/DMEM was
exchanged for fresh sterile 50/50 FBS/DMEM and incubated at 37˚C overnight again.

3.2.2 Aseptic Cell Culture
For all endocardium seeding experiments, coronary vasculature seeding
experiments, and the first endocardium reconstitution experiment, hAOECs (CC-2535)
were purchased from Lonza (Basel, Switzerland). Endothelial cells were expanded to
passage 4 and frozen down in Dimethyl Sulfoxide (DMSO). For all endocardium seeding
experiments and coronary vasculature seeding experiments, passage 4 hAOECs were
thawed and expanded to passage 8 or passage 9. Endothelial cells received from Lonza
for the first endocardium reconstitution experiment were expanded from passage 0 to
passage 7. For the last two endocardium reconstitution experiments, hAOECs (304-05a)
were purchased from Cell Applications (San Diego, CA) and expanded from passage 2 to
passage 9. All three endocardium reconstitution experiments used hADSCs. For the first
endocardium reconstitution experiment, hADSCs were expanded from passage 0 to
passage 5. For the second and third endocardium reconstitution experiments, hADSCs
were expanded from passage 0 to passage 5 and differentiated to fibroblast cells.
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Transforming Growth Factor Beta-1 (TGFB-1, 100-21) was purchased from PeproTech
(Rocky Hill, NJ) and administered to hADSCs in a concentration of 2ng TGFB-1 per mL
of media for differentiation.94

3.2.3 Endocardium Seeding Experiment Procedures
All three endocardium recellularization experiments began by preparing and
resuspending human aortic endothelial cells hAOECs in 2 mL of endothelial cells media
(CC-3162, Lonza, Basel, Switzerland). Cells were counted and split into two vials
containing 1 mL of cell suspension each. The first vial was administered into the left
ventricle through the aorta and the second vial was administered into the right ventricle
through the pulmonary trunk using a syringe.
For endocardium seeding experiment 1, 8.36x105 cells were seeded into the left
ventricle and 4.36x105 cells were seeded into the right ventricle. Both ventricles were
sealed by suturing the aorta and pulmonary trunk closed to prevent the cell suspensions
from escaping the ventricles. The cell seeded scaffold was placed inside a sterile p-cup
filled with endothelial cell media and incubated at 37˚C while left static and untouched
for 3 days. Following 3 days of incubation, the cell seeded scaffold was placed into 10%
buffered formalin in a 10:1 ratio of formalin volume to tissue volume for 4 days until
analysis began.
For endocardium seeding experiment 2, 5.61x106 cells were seeded into each
ventricle. Both ventricles were sealed by suturing the aorta and pulmonary trunk closed to
prevent cell suspensions from escaping the ventricles. The cell seeded scaffold was
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placed into a 50mL Bio-Reaction tube ( 229475, Cell Treat, Pepperell, MA). Media was
filled into the Bio-Reaction tube until the brim of the cell seeded scaffold was barely
submerged. The Bio-Reaction tube containing the cell seeded scaffold and endothelial
cell media was centrifuged at 400G for 10 minutes. The cell seeded scaffold remained
submerged in media inside the Bio-Reaction tube overnight incubated at 37˚C. The
following day, endothelial cell media was exchanged for fresh media and the BioReaction tube was incubated overnight at 37˚C again. After the second overnight
incubation period, the cell seeded scaffold was placed into 10% buffered formalin in a
10:1 ratio of formalin volume to tissue volume for 4 days until analysis began.
Endocardium seeding experiment 3 was conducted using the same protocol as
the second endocardium seeding experiment except with a different cell concentration. In
this experiment, 1.95x106 cells were seeded into the left ventricle and 2.27x106 cells were
seeded into the right ventricle.

3.2.4 Coronary Seeding Device Design
A seeding stand and funnel was designed and 3-D printed to assist in gravitation
seeding. The funnel was printed with digital Acrylonitrile Butadiene Styrene-2 (ABS-2)
using Stratasys Polyjet technology on an Object Connexx350 printer. A Stratasys FDM
360mc printer was used with ABS to print the stand. The internal tunnel of the funnel and
selected outside regions of the stand were treated with sigmacote (SL2-25ML, SigmaAldrich, ST. Louis, MO) to siliconize the surfaces. The silicon layer prevented cells and
media from infiltrating into the porous structure of the stand and funnel. To prevent the
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cell suspension from entering the left ventricle instead of the coronary vasculature, a
stopcock was added in between the funnel and the scaffold’s aorta. A lure was connected
to the stopcock and tubing was used to connect the stopcock’s lure to the funnel. An
additional lure was connected to the other side of the stop cock and used to cannulate the
aorta of the scaffold. The coronary seeding device coupled with a stop cock was used in
both coronary seeding experiments. The stopcock was removed and replaced with a yconnector and two pieces of tubing to split the flow of fluids entering the funnel to adapt
the coronary seeding device for other experiments. This adaption was used to incorporate
the coronary seeding device into hydrogel experiment 2 and all 3 endocardium
reconstitution experiments. The method for adapting the coronary seeding device will be
explained in more detail in the methods for those experiments.

3.2.5 Coronary Seeding Experiment Procedures
In coronary seeding experiment 1, 14.66x106 hAOECs were prepared, counted
and resuspended in 1mL of media. Vybrant CFDA SE Cell Tracer Kit (V12883,
ThermoFisher Scientific) was used to fluorescently tag the endothelial cells by following
the provided protocol. The cell suspension was pipetted through the top siliconized
opening of the funnel, while the stopcock was positioned closed. Once the cell
suspension reached the top of the stopcock, the stopcock was slowly opened to allow the
cell suspension to gradually reach the aorta. This allowed for the aortic valve to close and
the cell suspension to reside just above the aorta as it entered the coronary vasculature.
The seeding device, scaffold, and cell suspension was carefully moved to an incubator
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and remained untouched for 4 hours at 37˚C to allow time for cellular adhesion to the
scaffold’s coronary vasculature. Following incubation, the scaffold was removed from
the seeding device and a lure cap was attached to the lure cannulating the aorta. The
scaffold was immediately transported the Godley Snell facility in Clemson, SC. An in
vivo imaging system (IVIS) was used to image the fluorescently tagged hAOECs adhered
to the coronary vasculature of the scaffold. Afterwards, the scaffold was placed in 10%
buffered formalin in a 10:1 ratio of tissue volume to formalin volume for 4 days.
Following formalin fixation, samples of the coronary vasculature were dissected from the
scaffold and used in histology.
For coronary seeding experiment 2, 5.75x106 hAOECs were prepared and
suspended in 1 mL of media. The cell suspension was pipetted through the top siliconized
opening of the funnel, while the stopcock was position closed. Once the cell suspension
reached the top of the stopcock, the stopcock was slowly opened to allow the cell
suspension to gradually reach the aorta. The seeding device, scaffold, and cell suspension
was carefully moved to an incubator and remained untouched for 4 hours at 37˚C.
Following incubation, the scaffold was removed the seeding device and placed into 10%
buffered formalin in a 10:1 ratio of tissue volume to formalin volume for 4 days.
Afterwards, samples of the coronary vasculature were dissected from the scaffold and
used in histology.

3.2.6 Adaptor Plug Design
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An acrylic chamber originally designed by Dr. Lee Sierad for housing an aortic
root was adapted to house the decellularized scaffold. To adapt the chamber, a plug was
developed to secure the decellularized scaffold at the bottom of the chamber. The plug
was designed to limit the available open space surrounding the decellularized scaffold to
limit the movement of the scaffold as the chamber rotated. Holes were strategically
placed in the plug to allow media follow between the decellularized scaffold and the rest
of the chamber. ABS was used to 3-D print the adaptor plug on a Stratasys FDM 360mc
printer. The plug was treated with acetone to seal external pores. A metal ring originally
designed by Dr. Lee Sierad for securing an aortic root in the chamber was used to fill the
space between the lid of the chamber and the plug. By filling this space, the metal ring
kept the adaptor plug in place to assist in securing the decellularized scaffold. The
adaptor plug was used in hydrogel experiment 2 and endocardium reconstitution
experiment 1.

3.2.7 Hydrogel Infusion Experiment Procedures
In hydrogel experiment 1, 8 circular samples were cut from decellularized
scaffolds. Four of the samples underwent lyophilization and four remained untreated.
Following lyophilization, 3 lyophilized samples and 3 wet samples were placed into a 6well plate. One lyophilized sample and one wet sample did not receive hydrogel
administration to be kept as negative controls. The collagen portion of the hydrogel was
made using PureCol (5005-100ML, Advanced BioMatrix, San Diego, CA) and
neutralized using sodium hydroxide. The fibrin portion of the hydrogel was made using
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fibrinogen from bovine plasma (9001-32-5, Sigma-Aldrich), thrombin from human
plasma (9002-04-4, Sigma-Aldrich), and calcium chloride. Both hydrogels were mixed
together prior to either hydrogel solidifying. The final mixture yielded a collagen-fibrin
hydrogel composed of 1.15625 mg/mL fibrinogen, 0.592 mg/mL collagen, 0.0765
units/mL thrombin, and 2mM CaCl2 in 1xPBS. Once the final hydrogel mixture was
prepared, 200 µL was pipetted over the top of each lyophilized and wet sample in the 6well plate. DMEM was pipetted around the wet samples such that DMEM reached the
brim of each sample. The 6-well plate was moved to an incubator and kept untouched at
37˚C for 48 hours. After the 48-hour waiting period, DMEM was removed from the wet
tissue sample wells and 10 % buffered formalin was filled into every well of the 6-well
plate. The wells were large enough to allow a 10:1 formalin volume to tissue volume
ratio. Samples were fixed in the formalin for 4 days before analysis.
In hydrogel experiment 2, a decellularized scaffold was checked for non-sutured
holes or vessels unbound by ligation. Any holes or unbound vessels were sutured closed
except for the aorta and pulmonary trunk. Lures from decellularization remained
cannulated in the aorta and pulmonary trunk. The scaffold was washed with 1xPBS three
times for one hour per wash to remove any remnants of the storage solution. The seeding
stand and funnel was prepared similar to coronary seeding experiments. A small piece of
tubing was attached to the funnel, followed by a y-connector, and two similar lengths of
tubing was connected to each branch of the y-connector. The lure cannulating the aorta of
the scaffold was attached to one of the similar length pieces of tubing and the lure
cannulating the pulmonary trunk of the scaffold was attached to the other similar length
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piece of tubing. This allowed any fluid flowing from the funnel to be split and poured
into both ventricles of the scaffold at the same time. A mixed collagen-fibrin hydrogel
was prepared using the same components as before. However, this time the thrombin was
not mixed with the hydrogel mixture. The mixed hydrogel concentration was 1.2614
mg/mL fibrinogen, 1.248 mg/mL collagen, and 2 mM CaCl2 in 1xPBS. The hydrogel
solution was pipetted through the top of the funnel filling both ventricles of the scaffold
simultaneously.
The scaffold was removed from the stand and lure screw caps was placed on top
of both lures to seal the hydrogel mixture inside of the ventricles. An acrylic chamber and
acrylic chamber lid originally designed for an aortic root was used in combination with
the designed plug adaptor and a metal ring to house the scaffold. The chamber was
attached to an end-over-end rotator system and LabVIEW (National Instruments, Austin,
TX) was used to control speed, duration, and cycles of the rotator. The decellularized
scaffold was rotated for 15 minutes at 5 rpm on bench top. Following rotation, the
decellularized scaffold was removed from the chamber and placed into a 250mL wide
mouth conical tube. Additional hydrogel solution of the same composition as filled into
the scaffold’s ventricles was poured around the scaffold to the brim of the highest portion
of the scaffold in the conical tube. The conical tube containing the scaffold was
centrifuged at 500G for 15 minutes at 4˚C. Following centrifugation, the scaffold was
removed from the conical tube and excess hydrogel mixture was poured out from the
ventricles.
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The scaffold was then placed back onto the stand and funnel by connecting the
lures of the pulmonary trunk and aorta to the two similar length pieces of tubing. A
0.15708 units/mL thrombin in 1xPBS solution was pipetted through the top of the funnel
filling both ventricles of the scaffold simultaneously. The scaffold was detached from the
stand and funnel. Lure screw caps was attached to the lures cannulating the vessels to seal
the thrombin solution inside the ventricles and the scaffold was placed back into the
wide-mouth 250 mL conical tube. Thrombin solution of the same composition as filled
into the ventricles of the scaffold was poured around the scaffold up to the brim of the
highest portion of the scaffold in the conical tube. The conical tube containing the
scaffold was centrifuged at 500G for 15 minutes. Following centrifugation, excess
thrombin solution was poured from the ventricles of the scaffold. The scaffold was placed
back into the chamber and the adaptor plug and metal ring was used to secure the scaffold
at the bottom of the chamber. The chamber was filled with 1xPBS. Afterwards, the
chamber was re-attached to the end-over-end rotator and rotated for 48 hours at 1 RPM
on bench top. Following the 48-hour rotation period, the scaffold was removed from the
chamber and fixed in 10% buffered formalin in a 10:1 formalin volume to tissue volume
ratio for 4 days before analysis.

3.2.8 Bioreactor Design
A bioreactor was designed and manufactured for rotating and incubating the cell
seeded scaffold for the second and third endocardium reconstitution experiments. The
bioreactor was composed of four components. Two of the components were a pyramidal
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cage and lid designed to secure the scaffold near the center of the chamber. The cage and
lid was 3-D printed using ABS on a Stratasys FDM 360mc printer. Prior to use, the cage
and lid was treated with acetone to seal all external pores. The other two components of
the bioreactor were an acrylic chamber and acrylic chamber lid machined and polished
for transparency. The acrylic chamber housed the scaffold secured in the pyramidal cage
and lid. To account for a large number of cells seeded into the scaffold, the acrylic
chamber was designed to hold roughly 500 mL of media. Three threaded holes were
positioned on the acrylic chamber lid for the attachment of three sterile filters to allow
gas exchange. The acrylic chamber lid is held in place by a combination of an O-ring seal
and screws. Sterile gauze was used to line the inside of the pyramidal cage and lid to
cushion and assist in securing the scaffold.

3.2.9 Endocardium Reconstitution Experiment Procedures
For endocardium reconstitution experiment 1, two decellularized scaffolds
were used at the same time. Both scaffolds underwent the same experimental procedure
with one scaffold going through each step of the procedure directly after the first
scaffold. The scaffolds were attached to the seeding stand and funnel in the same fashion
as the scaffold used in the second hydrogel infusion experiment. Lures left over from the
decellularization procedure remained cannulated in the aortas and pulmonary trunks of
the decellularized scaffolds. The lures cannulated in the aorta and pulmonary trunk were
attached to the two similar length pieces of tubing such that fluid flowing from the funnel
would spilt and simultaneously fill both ventricles of the attached scaffold. A hydrogel
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mixture was prepared using the same components as the hydrogel mixture used in the
hydrogel infusion experiments. The final composition of the hydrogel solution was
1.2614 mg/mL fibrinogen, 1.248 mg/mL collagen, and 2 mM CaCl2 in 1xPBS.
After the first scaffold was attached to the stand and funnel, the hydrogel solution
was pipetted through the top of the funnel, filling both ventricles simultaneously. The
first scaffold was removed and lure screw caps were attached to the cannulation lures to
seal the hydrogel mixture inside the ventricles. After this step was repeated with the
second scaffold, both scaffolds were placed into acrylic chambers with acrylic chamber
lids originally designed for aortic roots. Two plug adaptors and metal rings were used to
secure both scaffolds in their chambers. The chambers were attached to the end-over-end
metal rotator used in the hydrogel experiments. LabVIEW was used to control the speed,
duration, and number of rotation cycles. The chambers were rotated at 5 rpm for 15
minutes on bench top. Afterwards, the scaffolds were removed from the chambers and
placed into separate 250mL wide-mouth conical tubes. The conical tubes were
centrifuged for 15 minutes at 500G at 4˚C. Following centrifugation, excess hydrogel
mixture was poured out of the ventricles of the scaffolds. Two cell lines, hAOECs and
hADSCs, were prepared, counted, and both cell lines were suspended together in 1xPBS
supplemented with 0.15708 units/mL thrombin. The ratio of cells in the cell suspension
was 114:1 hAOECs:hADSCs with 143x106 hAOECS and 1.25x106 hADSCs. Once the
cell suspension was prepared, it was split into two with one aliquot per scaffold.
The first scaffold was re-attached to the stand and funnel. One of the cell
suspension aliquots was pipetted into the top of the funnel, filling both ventricles of the
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first scaffold simultaneously. The first scaffold was removed and screw lure caps was
used to seal the cell suspension inside the ventricles. After these steps were repeated for
the second scaffold, both scaffolds were placed back into separate 250 mL wide-mouth
conical tubes and centrifuged at 500G at room temperature for 15 minutes. Following
centrifugation, the scaffolds were removed from the conical tubes and excess cell
suspension was poured out of the ventricles. Both scaffolds were placed into separate
chambers originally designed for aortic roots. Adapter plugs and metal rings were used to
secure the scaffolds at the bottom of the chambers. A mixture of half stromal media
(LaCell Inc.) and half endothelial cell media was used to fill the chambers. Both
chambers were attached to the end-over-end rotator and rotated for 1 rpm for 48 hours
inside an incubator at 37˚C.
Following the 48-hour rotation period, two cell lines, hAOECs and hADSCs,
were prepared, counted, and then suspended together in endothelial cell media. The ratio
of cells in the cell suspension was 144:1 hAOECs:hADSCs with 260.4x106 hAOECS and
2.284x106 hADSCs. Once the cell suspension was prepared, it was split into two with one
aliquot per scaffold. Both scaffolds were removed from the chambers and the first
scaffold was attached to the stand and funnel. One of the cell suspension aliquots was
pipetted through the top of the funnel such that both ventricles of the scaffold filled
simultaneously. The first scaffold was removed and lure screw caps were used to seal the
cell suspension inside the ventricles. After these steps were completed for the second
scaffold, both scaffolds were placed back into separate chambers. The media in both
chambers were replaced with fresh 50/50 stromal media/endothelial media. Adapter plugs
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and metal rings were used to secure the scaffolds at the bottom of the chambers. Both
chambers were re-attached to the end-over-end rotator and rotated for 4 days at 1 rpm.
Fresh media was replaced in both chambers as needed when indicated by visible media
color change. After 4 days of rotating both scaffolds were fixed in 10% buffered formalin
for 4 days in a 10:1 formalin volume to tissue volume ratio.
Endocardium reconstitution experiment 2 and 3 were performed identical to
one another with the same cell concentrations to show the results are reproduceable. To
begin these experiments, the decellularized scaffold was attached to the seeding funnel
and stand. The aorta and pulmonary trunk of the scaffold were still cannulated with lures
from decellularization. Tubing and a y-connector were used to split the flow from the
funnel as previously stated in the first endocardium reconstitution experimental
procedure.
The application of the first layer of the layer-by-layer technique began with a
collagen hydrogel solution. The collagen hydrogel was prepared using the same
components as previously stated in the hydrogel infusion experimental procedures with a
concentration of 2.5 mg/mL. The collagen hydrogel solution was pipetted through the top
of the funnel, filling both ventricles of the scaffold simultaneously. Afterwards, the
scaffold was removed from the funnel and stand. Lure screw caps were used with the
cannulation lures to seal the collagen hydrogel solution inside the ventricles of the
scaffold. The scaffold was placed into the assembled bioreactor. The bioreactor was filled
with sterile ice to prevent the collagen hydrogel from prematurely solidifying.
Afterwards, the bioreactor was attached to the end-over-end rotator and rotated on bench
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top for 15 minutes at 5 rpm. Following rotation, the sterile ice was emptied from the
bioreactor and the scaffold was placed into a 250mL wide-mouth conical tube. The
conical tube was centrifuged for 15 mins at 4˚C and 500G. After centrifugation, excess
collagen hydrogel solution was emptied from the ventricles prior to hydrogel
solidification. The scaffold was placed into a sterile p-cup and left untouched in an
incubator for 30 mins at 37˚C while the infused collagen hydrogel solidified. Meanwhile
fibroblast differentiated from hADSCs were prepared, counted, and suspended in DMEM
with 5% FBS 1% Antibiotic-Antimycotic (AB-AM, MT30004CI, Fisher Scientific).
Following the incubation period, the scaffold was re-attached to the stand and funnel. A
total of 13.4x106 fibroblast cells suspended in media were pipetted through the top of the
funnel filling both ventricles simultaneously. Afterwards, the scaffold was removed from
the stand and funnel and the ventricles were sealed off with the lure screw caps. The
scaffold was placed back into the assembled bioreactor. The bioreactor was filled with
DMEM 5%FBS 1% AB-AM. Once the bioreactor was filled and reassembled, the endover-end rotator was placed into an incubator and the bioreactor was attached. The
bioreactor rotated overnight at 1rpm and 37˚C.
Following the overnight rotation in the incubator the scaffold was removed from
the bioreactor and attached to the stand and funnel. The last addition of the first layer of
the layer-by-layer technique was the application of an additional collagen hydrogel
solution. The collagen hydrogel solution was prepared with the same components and the
same concentration as before. Once prepared, the collagen hydrogel solution was pipetted
through the top of the funnel, filling both ventricles of the scaffold simultaneously. The
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scaffold was left untouched for a minute to allow the collagen hydrogel solution to briefly
soak into the ventricles. Afterwards, the excess collagen hydrogel solution was poured
from the ventricles. Lure screw caps were used to seal off the ventricles and the scaffold
was placed back into the assembled bioreactor. The bioreactor was placed into an
incubator and allowed to set untouched for 30 minutes at 37˚C while the remaining
collagen hydrogel solution solidified. Meanwhile, a 3.4 mg/mL fibrinogen solution was
prepared in ddH2O. After the incubation period, the scaffold was removed from the
bioreactor and re-attached to the funnel and stand.
The application of the second layer of the layer-by-layer technique began with the
addition of the fibrinogen solution. The fibrinogen was pipetted through the top of the
funnel, filling both ventricles of the scaffold simultaneously. Afterwards, the scaffold was
removed from the funnel and stand and the ventricles were sealed with lure screw caps.
The scaffold was placed back into the assembled bioreactor and re-attached to the endover-end rotator. On bench top, the bioreactor was rotated for 15 minutes at 5 rpm.
Following rotation, the scaffold was removed from the bioreactor and placed into a
250mL wide-mouth conical tube. The conical tube was centrifuged at 500G and room
temperature for 15 minutes. After centrifugation, the scaffold was removed from the
conical tube and excess fibrinogen solution was poured from the ventricles. A thrombin
solution containing 0.15708 units/mL thrombin and 2mM CaCl2 suspended in DMEM
with 5% FBS 1% AB-AM was prepared. The scaffold was re-attached to the funnel and
stand and the thrombin CaCl2 solution was pipetted through the top of the funnel, filling
both ventricles simultaneously. Then the scaffold was removed from the funnel and stand
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and both ventricles were sealed using lure screw caps. The scaffold was placed back into
the assembled bioreactor and left in an incubator untouched overnight at 37˚C.
Following overnight incubation, hAOECs were prepared, counted, and suspended
in endothelial cell media (211K-500, Cell Applications). A total of 161.75x106
endothelial cells were suspended in the cell suspension. The scaffold was removed from
the bioreactor and excess thrombin CaCl2 solution was poured from the ventricle.
Afterwards, the scaffold was attached to the stand and funnel and the endothelial cell
suspension was pipetted through the top of the funnel, simultaneously filling both
ventricles of the scaffold. The scaffold was removed from the stand and funnel and the
ventricles were sealed using lure screw caps. This step concluded the last addition for the
second layer of the layer-by-layer technique. Once the ventricles were sealed, the scaffold
was placed back into the bioreactor. Media was removed from the bioreactor and
replaced with 50/50 endothelial cell media/DMEM with 5% FBS 1% AB-AM. The
bioreactor was re-attached to the end-over-end rotator and rotated in an incubator at 1
rpm and 37˚C overnight.
The following day, the scaffold was removed from the bioreactor and excess
endothelial cell suspension was poured from the ventricles. Afterwards, the scaffold was
placed back into the assembled bioreactor. Cell media in the bioreactor was exchanged
for fresh cell media of the same mixture and concentration. The bioreactor was reattached to the end-over-end rotator and rotated in an incubator at 1 rpm and 37˚C for
three days. Cell media was replaced with fresh cell media of the same mixture and
concentration once a day and sterile filters were replaced as needed. Following the three
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days of rotation, the scaffold was removed from the bioreactor and fixed in 10% buffered
formalin in a 10:1 formalin volume to tissue volume ratio. Fixation occurred for 4 days
before analysis began.

3.2.10 Histology and IHC
Following formalin fixation, samples were obtained from every experiment for
histology. For the first endocardium seeding experiment, circular samples were cut form
the ventricles and used for histology. For the first hydrogel experiment, circular samples
were cut from the scaffold prior to the experiment. Afterwards, those samples were used
for histology. In all other experiments rectangular samples were cut from the hydrogel
infused or cell seeded scaffolds and used for histology. In all experiments, except for the
second hydrogel experiment, the samples were orientated along the ventricular
circumferential axis during embedding. This provided sections with visible endocardium,
myocardium, and epicardium. For the second hydrogel experiment, left ventricle and
right ventricle samples were orientated in one of two ways while embedding. The first
way was along the ventricular circumferential axis analogous to all other experiments.
The second way was along the ventricular perpendicular axis. This provided sections
where only the myocardium was visible. Septum samples from the second hydrogel
experiment were only oriented along the ventricular circumferential axis. In all
experiments, the same protocol was used for processing the tissue samples, dehydration,
sectioning, and rehydration, as previously described in the histology section of chapter 2.
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The histology conducted for the first endocardium recellularization experiment
was DAPI fluorescent nuclear stain, Hematoxylin and Eosin (H&E) stain, and Alcian
Blue stain. DAPI fluorescent nuclear stain was performed using the same protocol as
described in the histology section of chapter 2. For H&E stain, histological slides were
rehydrated to distilled water, exposed to hematoxylin for 10 minutes, rinsed with tap
water, and dipped 6 times in clarifier. Then the histological slides were rinsed with tap
water, exposed to bluing reagent for 1 minute, rinsed in tap water for 1 minute, dipped in
95% ethanol 10 times, and placed in Eosin for 45 seconds. Afterwards, the histological
slides were dehydrated in an ethanol gradient, dipped 10 times in xylene, placed in xylene
for 5 minutes, mounted with mounting media, and covered with coverslips. For Alcian
Blue stain, histological slides were rehydrated to distilled water, mordanted in 3% acetic
acid for 3 minutes, exposed to 1% Alcian Blue in 3% acetic acid (pH 2.5) for 30 minutes,
and rinsed in running water for 10 minutes. Afterwards, the histological slides were
rinsed in distilled water, counter-stained in 0.1% nuclear fast red in distilled water for 5
minutes, and washed in running water for 1 minute. Then the histological slides were
dehydrated in an ethanol gradient, mounted with mounting medium, and covered with
coverslips.
The histology conducted in all other experiments were DAPI fluorescent nuclear
stain and Masson’s Trichrome stain. Both histology stains were performed according to
the protocols described in the histology section of chapter 2. For the second and third
endocardium reconstitution experiments IHC was performed staining for laminin
proteins. The protocol used for this IHC stain was the same protocol as described in the
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histology section of chapter 2. The microscope and imaging software described in the
histology section of chapter 2 remained the same for imaging all experiments depicted in
this chapter.

3.2.11 DAPI Quantification Using Image J
For the third endocardium seeding experiment, second coronary seeding
experiment, and first two endocardium reconstitution experiments, the images obtained
from DAPI stained histological slides were quantified using Image J (National Institutes
of Health, Bethesda, MD). First, one section was chosen per histological slide of each
sample. This section was imaged in 10x magnification. The entire section was imaged
with careful regard not to duplicate any areas of the section on the images.
Every image was subject to the following procedure. In Image J, the contrast
setting was moved to the highest setting. Brightness was adjusted differently for each
image such that the fluorescing nuclei are present but the background and scaffold are no
longer yielding false positives in the image. Due to variability in lighting when imaging
the sections, the same brightness setting could not remain constant without skewing the
data. Once the brightness and contrast settings were adjusted, the images were made
binary and analyzed for particles. Image J provided a particle count. This particle count
was recorded for every image and summed together for each section. Particle counts were
normalized by the area of the sample. Using 2.5x magnification and white light, the
previously imaged sections were imaged again with careful regard not to duplicate any
areas of the section on the images. The scale bar for 2.5x magnification was measured to
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be 202.66667 pixels per 500 µm. This conversion was used for every image. Once the
scale was adjusted, the freehand tool of image J was used to trace the outline of the
samples present on every image. Image J provided the area of each traced outline.
Particle counts were normalized by diving the summed particle count of the section by
the summed area of the section, yielding units of cells/mm2. The data obtained for each
sample was averaged with other samples obtained from the same ventricle to calculate a
left and right ventricular average for each experiment.
To compare these normalized particle counts to a positive control, fresh native
samples were also analyzed using a similar approach. Native sections were assumed to be
homogenous in cell density within the heart wall. Two samples from each ventricle, one
sample from each coronary artery branch, and one sample from the coronary sinus were
obtained and put through the same histological process as described above. All native
histological slides were stained with DAPI fluorescent nuclear stain. One section was
chosen per histology slide and six images were obtained without duplicating areas across
images. Each region imaged was carefully selected such that there was no void space in
any image. The scale bar for 10x magnification was measured to be 154.6667 pixels per
100 µm. The size of the image was measured in pixels and converted to micrometers.
Particles were counted using the same method as described above and normalized using
the area of the image, yielding units of cells/mm2. The data obtained from each image
was averaged with other images from the same sample to yield sample averages. Samples
averages from the same ventricle were averaged to yield a left and right ventricular
average.
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To obtain a ventricular seeding efficiently for each ventricle to represent the
percentage of cells seeded back into the decellularized heart wall, the following equation
was used: 100 – (((native ventricle average – experiment ventricle average)/(native
ventricle average))*100).

3.2.12 Trichrome Quantification Using Image J
For the second hydrogel infusion experiment and the second endocardium
reconstitution experiment, the images obtained from Masson’s Trichrome stained
histology slides were quantified with Image J. First, one section was chosen per
histological slide of each sample. This section was imaged in 2.5x magnification. The
entire section was imaged with careful regard not to duplicate any areas of the section on
the images.
Every image was subject to the following procedure. In Image J, the freehand tool
was used to trace the outline of the section. The scale was adjusted such that 202.6667
pixels was equivalent to 500 µm. Afterwards, the traced outline was measured to
calculate an area of the section in µm2. Four image duplicates were made using the traced
outline. This ensured the duplicates would have a minimum of free space surrounding the
sections to limit false positives. The first duplicate was measured for the first half of the
red content present in the image. In image J, the color threshold was adjusted in HSB.
The Hue range was changed to 0-13. The saturation range was adjusted to be close to end
of the provided curve such that red content was fluorescing while the background content
did not contain visible false positives. This saturation range changes from section to
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section. To stay consistent per image, the saturation range was recorded and kept constant
for each duplicate of an original image. Brightness range was adjusted to the absolute end
of the provided curve. The brightness range also changes from section to section.
However, the brightness range was recorded and kept constant for each duplicate of an
original image. The duplicate image’s brightness and contrast where both raised to the
highest provided value. Afterwards, the duplicate image was made binary and analyzed
for particles. Instead of recording the total particles, the total area of all particles
combined was recorded.
For the second duplicate image, the same procedure for the first duplicate image
was followed with one exception. The second half of the red content was measured by
adjusting the hue range to 232-255. The third duplicate image was used to measure the
amount of blue content. To accomplish this, the same protocol was used as the first two
duplicate images with one exception. The hue range was adjusted to 151-187.
The fourth duplicate image followed a different protocol. All color except white
was measured in this duplicate image. An area of all color except white resulted in the all
the tissue in the image fluorescing. By subtracting the total area obtained from the traced
outline and the measured area of all color except white, we could calculate a value
representative of the pore area of the section imaged. To obtain a measurement of all
color except white, we adjusted the color threshold in RGB. Green and blue ranges were
both set to 0-255. Red range varied from image to image. We adjusted the red range to be
0-X, such that ‘X’ was the value that yielded the most scaffold fluorescing without
having white false positives in the background.
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For each section, all like-values across the images of a section where summed
together. Percentages of the amount of fibrin area, pore area, and collagen area in each
section were calculated. The first half of the red content and the second half of the red
content were added together. This new value of total red content was divided by the value
found for all color except white. This ratio was multiplied by 100 to yield the fibrin
percent of the section. To calculate collagen percent, the blue content was divided by the
value found for all color except white. Afterwards, this ratio was multiplied by 100.
Percentages for the pore area of the sections were calculated by the following equation:
((Traced outline area – All color area except white)/(Traced outline area))*100. Samples
of the same ventricle were averaged together to obtain ventricular averages. A negative
control was obtained by applying the same procedure to untreated decellularized scaffold
histological slides stained with Masson’s Trichrome stain.

3.2.13 Statistics
Data obtained from Image J quantification of histology was averaged for samples
from the same ventricle and standard deviations were calculated for each average. A
student t-test was used for several comparisons. The first student t-test was used in the
second hydrogel experiment to compare decellularized samples with hydrogel infused
samples where each compared data set kept orientation and ventricle constant. Another
student t-test compared cell seeded samples from the second endocardium reconstitution
experiment with hydrogel infused samples of the same orientation and ventricle from the
second hydrogel experiment. Lastly, an additional student t-test compared cell seeded
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samples from the second endocardium reconstitution experiment with decellularized
samples of the same orientation and ventricle from the second hydrogel experiment. JMP
(SAS, Cary, NC) was used to perform an in-depth statistical analysis using ANOVA on
data generated by Image J quantification of Masson’s Trichrome stain. P-values
representing the significance of each factor were generated by JMP for summaries across
multiple data types (collagen percent, fibrin percent, and pore percent) from the same
experiment. Significant factors (p-value < 0.05) were further analyzed in JMP with
individual ANOVA tables for each data type and linear contrasts.
Table 1: List of Experiments
Experiment

Rationale

Methods

Outcomes

Endocardium

Evaluate cellular

Static cell seeding

Scaffold supports

Seeding

adhesion and

viability and cellular

Experiment 1

viability on

attachment.

scaffold surface.
Endocardium

Evaluate cellular

Centrifugal cell seeding

Cells can infiltrate

Seeding

adhesion and

subendothelium

Experiment 2

infiltration in

through surface pores.

scaffold

Improved adhesion

subendothelium.

compared to static
seeding beneath the
acellular ventricular
surface.

Endocardium

Verify

Seeding

reproducible

Centrifugal cell seeding

Verified reproducible
results from
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Experiment 3

results from

Endocardium Seeding

Endocardium

Experiment 2.

Seeding

Centrifugal seeding

Experiment 2 and

yielded poor cell

determine cell

distribution.

distribution inside
both ventricles.
Coronary

Evaluate feasibility

Gravitational cell

Seeding technique

Seeding

of seeding

seeding through seeding

supports infiltration in

Experiment 1

technique for

device and stop cock,

large vessels. Poor

infiltrating cells

immunofluorescence

results in small

into coronary

vessels.

vasculature.
Coronary

Verify

Gravitational cell

Verified reproducible

Seeding

reproducible

seeding through stop

results from Coronary

Experiment 2

histological results

cock

Seeding Experiment 1.

from Coronary

Cells accumulated

Seeding

most in the coronary

Experiment 1 and

sinus. Right and

determine cell

circumflex coronary

distribution in

arteries had similar

large coronary

seeding efficiencies.

vessels.
Hydrogel

Evaluate

Lyophilization versus

Lyophilization does

Experiment 1

lyophilization

wet tissue in static

not allow for more

influence on

hydrogel infusion

hydrogel infusion

hydrogel infusion.

beneath the ventricular
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surface.
Hydrogel

Evaluate hydrogel

Gravitational,

Hydrogel infiltrates

Experiment 2

infiltration into

centrifugal, and

into perpendicular

scaffold’s pores,

rotational hydrogel

pores better than

distribution of

infusion. Samples

circumferential pores.

hydrogel inside

embedded into paraffin

Hydrogel distributes

scaffold’s

along circumferential

well along

ventricles, and

axis or along

perpendicular axis but

hydrogel adhesion

perpendicular axis.

not along

on scaffold’s

circumferential axis.

surface.

Poor adhesion to
surface.

Endocardium

Evaluate cellular

Gravitational,

Combined techniques

Reconstitution

adhesion and

centrifugal, and

improve cellular

Experiment 1

distribution on

rotational cell seeding

adhesion compared to

scaffold surface

and hydrogel infusion

previous experiments.

after using this
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3.3 Results
3.3.1 Endocardium Seeding Experiments
Static seeding used in endocardium seeding experiment 1 resulted in cells
attaching on the surface of the ventricular cavities and in the subendothelium (Figure
18). DAPI fluorescent nuclear stain, H&E stain, and Alcian Blue stain all confirmed these
findings and were consistent with one another. Centrifugal seeding using in
endocardium seeding experiments 2 and 3 influenced cells to adhere to the
subendothelium beneath the surface (Figure 19). However, some of the cells were unable
to penetrate the surface and instead attached along the inner lining of the ventricular
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cavities. Nuclei quantification by Image J from DAPI fluorescent nuclear stain images of
endocardium seeding experiment 3 revealed a large variation amongst samples from
the same ventricle (Table 3). The seeding efficiency of endocardium seeding
experiment 3 was 0.099% of cells re-seeded into the left ventricle heart wall and 0.113%
of cells re-seeded into the right ventricle heart wall (Table 2,3).

Figure 19: Endocardium seeding experiment 1 histological analysis of native heart
and cell seeded scaffold. (A) DAPI fluorescent nuclear stain, (B) Hematoxylin and Eosin
(H&E) stain, and (C) Alcian Blue stain on native rabbit heart and cell-seeded scaffold.
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Bars are set to 100 µm. Red and black arrows depict cells seeded within the ventricular
cavities.

Figure 20: Endocardium seeding experiments 2 and 3 histological analysis of native
heart, decellularized scaffold, and cell seeded scaffold. (A) Native rabbit
endocardium, (B) decellularized scaffold and (C) cell-seeded scaffold stained with DAPI
fluorescent nuclear stain and Masson’s Trichrome stain. Bars are set to 100 µm. Red and
black arrows depict cells seeded within the pores of the scaffold. Native left ventricle and
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scaffold right ventricle DAPI fluorescent nuclear stain images were shown previously in
Figure 16 in chapter 2. These images are shown again for comparison.

Table 2: Native Heart Nuclei Quantified by Image J for Ventricles
Cells per Area
Cells per Area Averaged
Cells per Area
Cell Area
Sample Image
Averaged for Sample
for Ventricle (Cell
Standard Deviation for
Count (mm2)
(Cell Count/mm^2)
Count/mm^2)
Ventricle
1
1003
2
1026
Right
1326
Ventricle 3
1953.0
Sample
4
1223
1
5
950
6
1143
1942.6
293.6
1
1159
2
1428
Right
1182
Ventricle 3
1932.2
Sample
4
925
2
5
880
6
1026
0.569
1
1469
2
1321
Left
1242
Ventricle 3
2121.6
Sample
4
1093
1
5
1101
6
1021
1929.0
367.7
1
1205
2
1053
Left
751
Ventricle 3
1736.3
Sample
4
759
2
5
1178
6
985
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Table 3: Endocardium Seeding Experiment 3 Nuclei Quantified by Image J
Seeding Efficiency:
Cells per Cells per Area
Cells per
(100- ((Native Cells per
Cell Sample Area
Area
Standard
Ventricle Sample
Area (Cell
Area-Seeded Scaffold
Count (mm2)
Averaged Deviation for
Count/mm2)
Cells per Area)/Native
for Ventricle Ventricle
Cells per Area))*100
1
5
25.124
0.2
2
6
9.334
0.6
Left
2.0
1.9
0.1
3
76
26.760
2.8
4
80
19.388
4.1
1
68
31.173
2.2
2
126
25.8
4.9
Right
2.4
1.7
0.1
3
19
14.5
1.3
4
30
21.3
1.4

3.3.2 Coronary Seeding Experiments
The novelty of the coronary seeding device is that it allows for a rabbit heart to be
cannulated, held in place by the cannulation, and funnels a cell suspension into the aorta
using gravity (Figure 21). We Utilized two techniques to ascertain the effectiveness of
the coronary seeding device and stopcock for delivering cells into the coronary
vasculature. First, in coronary seeding experiment 1, we tagged the endothelial cells
with a cell tracer and imaged the scaffold using an IVIS machine. Second, we used
histology to verify the results from the IVIS generated images. The IVIS generated
images revealed endothelial cells successfully seeded into the left circumflex artery and
right coronary artery (Figure 22). DAPI florescent nuclear stain and Masson’s Trichrome
stain supported these finding. In coronary seeding experiment 2, nuclei quantification
by Image J from DAPI fluorescent nuclear stain images revealed the region with highest
cellular attachment was the coronary sinus (Table 5). The left coronary branch and right
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coronary branch both yielded similar results for seeding efficiency with 0.134% and
0.123% of cells reseeded into those regions respectively (Table 4, 5).
Coronary Seeding Device Design

B

A

D

C

Figure 21: Cell seeding device design (A) Solidworks designs showing cell seeding
stand and funnel. (B) Representative image of cell seeding stand and funnel in use during
coronary seeding experiments. Pink fluid is endothelial cell culture media, arrow points
to cannulated scaffold. Several bottle caps and a p-cup filled with cell media was used to
keep the cell-seeded scaffold suspended in media during cellular attachment to the
coronary vasculature. (C) Aerial view of funnel. (D) Assembled cell seeding stand and
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funnel adapted with tubing and y-connector for splitting fluid into both ventricles. This
adaptation was used in hydrogel experiment 2 and all 3 endocardium reconstitution
experiments.

Figure 22: Coronary seeding experiments 1 and 2 histological and fluorescent
analysis of cell-seeded coronary vasculature. (A) Left circumflex artery and (B) right
coronary artery stained with DAPI fluorescent nuclear stain and Masson’s Trichrome
stain. Bars are set to 100 µm. Red and black arrows depict cells seeded within the
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coronary vasculature. Cell tracer was used to fluorescently tag cells to identify their
attachment locations along both branches of coronary arteries. Scaffold overlay images
display the fluorescent regions overlaid onto the scaffold. Red and black arrows and
circles depict regions of cellular attachment within both branches of coronary
vasculature.
Table 4: Native Heart Nuclei Quantified by Image J for Coronaries
Cell Area Cells per Area Averaged for Cells per Area Standard Deviation for
Sample Image
Count (mm2) Coronary (Cell Count/mm^2)
Coronary
1
799
2
932
3
904
Coronary
1599.9
245.8
Sinus
4
886
5 1168
6
776
1
788
2
553
559
Circumflex 3
0.569
1130.9
314.8
Artery
4
927
5
439
6
597
1
826
2 1563
Right
3 1604
Coronary
1665.8
740.2
4
835
Artery
5 1553
6 1136
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Table 5: Coronary Seeding Experiment 2 Nuclei Quantified by Image J
Cells per Cells per Area
Seeding Efficiency: (100Sample Cells per
Sample
Cell
Area
Standard
((Native Cells per Area-Seeded
Area Area (Cell
Origin
Count
Average Deviation for Scaffold Cells per Area)/Native
(mm^2) Count/mm^2)
for Vessel
Vessel
Cells per Area))*100
Coronary
Sinus
11 2.247
4.9
(Sample 1)
3.3
2.2
0.2
Coronary
Sinus
4
2.284
1.8
(Sample 2)
Left
Coronary
14
5.8
2.4
Artery
1.9
0.7
0.1
Circumflex
5
3.6
1.4
Artery
Right
Coronary
16 6.865
2.3
Artery
(Sample 1)
2.3
0
0.1
Right
Coronary
6
2.560
2.3
Artery
(Sample 2)

3.3.3 Hydrogel Infusion Experiments
Majority of the pores of the lyophilized samples in hydrogel experiment 1 did
not have visual traces of solidified hydrogel depicted in Masson’s Trichrome stain
(Figure 23). Instead the collagen-fibrin hydrogel is shown along the surface of the tissue.
Wet tissue samples revealed regions of mixed collagen-fibrin hydrogel infused within the
myocardium pores.
The adaptor plug created for adapting the aortic root chamber could be used in
combination with a metal ring to securely fit decellularized rabbit hearts (Figure 24).
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Fluids used during experiments with the aortic root chamber and adaptor plug could still
circulate throughout the chamber via the pores of the adaptor plug.
In hydrogel experiment 2, Masson’s Trichrome stain revealed several patches of
mixed collagen-fibrin hydrogel infused within the myocardium but not on the
endocardium surface (Figure 25). Further analysis using Image J to quantify the amount
of blue (collagen), red (fibrin), and pore area yielded large standard deviations for
averages of decellularized samples (Table 6). Additionally, averages of hydrogel infused
samples oriented along the circumferential axis yielded larger standard deviations than
averages of hydrogel infused samples oriented along the perpendicular axis. A more indepth statistical analysis of the data generated by Image J using JMP revealed a
significant difference between the orientation of the samples (Table 7). Linear contrast of
perpendicular orientated hydrogel infused samples versus circumferential orientated
hydrogel infused samples yielded a significant difference for collagen percent (Table 8)
and pore percent (Table 10) and no significant difference for fibrin percent (Table 9).
The same linear contrasts were performed for decellularized scaffold samples with no
significant difference found for collagen percent, fibrin percent, or pore percent.
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Figure 23: Hydrogel experiment 1 histological analysis of lyophilized and wet
scaffold. (A) Wet scaffold tissue and (B) lyophilized scaffold tissue were left untouched
for a control or treated with a mixed collagen-fibrin hydrogel. All hydrogel treated
samples and controls samples were stained with Masson’s Trichrome stain. Bars are set
to 100 µm. Black arrows depict hydrogel attached along the surface or infused within the
pores of the samples.
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Adaptor Plug Design
A

2
1

3
4

5

B

D

E

C

F

Figure 24: Adaptor plug design. (A) Bioreactor components consisting of 1, metal ring,
2, adaptor plug, 3, acrylic chamber, 4, chamber lid, 5, screws used to attach assembled
device to an end-over-end rotator. (B) Solidworks designs showing bioreactor
components in an expanded assembly. (C) Solidworks designs showing assembled
bioreactor. (D) Solidworks design of the adaptor plug. (E) Solidworks designs showing
adaptor plug’s bottom view with arrows depicting holes for allowing fluid flow. (F)
Representative image of bioreactors and end-over-end rotator in use during endocardium
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reconstitution experiment 1. Red fluid is cell culture medium, black arrows point to heart
scaffolds inside bioreactors.

Figure 25: Hydrogel experiment 2 histological analysis of decellularized scaffold and
hydrogel infused scaffold. (A) A Decellularized scaffold was used as a control to
compare to (B) the hydrogel infused scaffold. All samples taken from the left ventricle,
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right ventricle, and septum of both scaffolds were stained with Masson’s Trichrome stain.
Samples from the left and right ventricles were oriented one of two ways, either along the
ventricular circumferential axis or along the ventricular perpendicular axis. Bars are set to
100 µm. Black arrows point to regions containing hydrogel infused into the ventricular
wall.
Table 6: Hydrogel Experiment 2 Masson's Trichrome Quantified by Image J
Fibrin
Collagen
Pore
Standard
Standard
Standard
Heart
Orientation Ventricle Percent
Percent
Percent
Deviation
Deviation
Deviation
Average
Average
Average
Decellularized

Perpendicular

Left

17.8

16.6

27.2

22.6

41.6

10.5

Decellularized

Perpendicular

Right

8.1

1.0

29.7

1.2

45.2

9.7

Perpendicular

Left

7.1

6.3

36.7

6.1

27.4

4.7

Perpendicular

Right

6.6

2.6

47.8

1.8

32.6

8.2

Decellularized Circumferential

Left

4.5

5.5

24.2

32.7

46.8

10.5

Decellularized Circumferential

Right

8.1

7.7

7.6

4.8

68.7

5.9

Circumferential

Left

15.6

16.2

7.6

8.7

64.7

20.3

Circumferential

Right

18.1

21.2

16.9

14.7

64.4

16.7

Hydrogel
Infused
Hydrogel
Infused

Hydrogel
Infused
Hydrogel
Infused

Table 7: Hydrogel Experiment 2 Effect Summary from JMP
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3.3.4 Endocardium Reconstitution Experiments
The right ventricles of hearts A and B, left ventricle of heart B, and septum of
heart A from endocardium reconstitution experiment 1 had cells adhered in thick
layers on top of the ventricular surface in the DAPI fluorescent nuclear stain images
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(Figure 26). The left ventricle of heart A revealed cells adhered to the surface of the
ventricle but not to the magnitude of the other surfaces previously mentioned. In heart B,
the septum had few regions of cells adhered to the surface but had cells integrate into the
inside of the septum wall through a large pore. Masson’s Trichrome displayed several
regions of mixed collagen-fibrin hydrogel adhered to the surfaces of the ventricular
cavities. Many regions of adhered regions of hydrogel had cells embedded into its
structure. Some pores within the myocardium were also infused with hydrogel. However,
both DAPI fluorescent nuclear stain and Masson’s Trichrome stain revealed regions of no
cellular or hydrogel attachment. DAPI fluorescent nuclear stain quantified by Image J
yielded a 7.6% and 8.1% seeding efficiency for the right ventricles of hearts A and B
respectively (Table 11). A seeding efficiency of 2.7% in the left ventricle of heart A and
13.8% into the left ventricle of heart B was achieved. However, the standard deviation for
the average cells per area of the left ventricles were very large compared to their
respective averages. Compared to previous cell seeding experiments, the standard
deviations for the average cells per area in the right ventricles where lower than before.
The purpose-built bioreactor could store roughly 500 mL of media at once while
housing the cell seeded scaffold at the center of the bioreactor (Figure 27). Three sterile
filters allowed for gas exchange. Once fully assembled, the bioreactor could attach to the
end-over-end rotator used in endocardium reconstitution experiment 1.
Endocardium reconstitution experiment 2 yielded patches of cellular and
hydrogel attachment to the surfaces of the ventricular cavities depicted by DAPI
fluorescent nuclear stain, Masson’s Trichrome stain (Figure 28), and SEM (Figures 29-
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31) of the left ventricle, right ventricle, and septum. IHC staining for laminin content
revealed cells actively secreted laminin once seeded into the ventricles. SEM images
depicted cells interacting with neighboring cells and integrated into the hydrogels. DAPI
fluorescent nuclear stain quantified by Image J yielded a seeding efficiency of 2.9% and
5.2% for the left and right ventricles respectively (Table 12). Standard deviations for the
averages of cells per area in both ventricles were similar to the standard deviations found
in endocardium reconstitution experiment 1. Masson’s Trichrome stain quantified by
Image J for blue (collagen), red (fibrin), and pore area yielded overlapping standard
deviations for fibrin area between like-ventricles of the cell seeded heart and
decellularized heart (Table 13). Pore area and collagen area did not have overlapping
standard deviations when comparing the right ventricles of the two hearts. However, pore
area and collagen area did have overlapping standard deviation when comparing the left
ventricles of the two hearts. Further analysis of the data generated by Image J using JMP
revealed a significate difference between the two hearts but also a significant interaction
between the two factors of heart and ventricle (Table 14). Using linear contrast of likeventricles between the two hearts, we only found a significant difference between the
pore area of the right ventricles (Tables 15-17). Additionally, the standard deviations
compared to their respective averages from the scaffold used in endocardium
reconstitution experiment 2 were smaller than the standard deviations from the scaffold
used in hydrogel experiment 2.
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Figure 26: Endocardium reconstitution experiment 1 histological analysis of
regenerated endocardium. (A) Left ventricle, (B) right ventricle, and (C) septum
samples of seeded scaffolds A and B stained with DAPI fluorescent nuclear stain and
Masson’s Trichrome stain. Bars are 100 µm. Red and black arrows depict seeded cells
and infused hydrogel along ventricular surfaces.
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Table 11: Endocardium Reconstitution Experiment 1 Nuclei Quantified by Image J
Cells per Seeding Efficiency:
Cells per
Cells per
Area
(100-((Native Cells
Seeded
Area
Cell Sample Area Area (Cell
Standard
per Area-Seeded
Scaffol Ventricle Sample
Averaged
Count (mm^2) Count/mm^2
Deviation Scaffold Cells per
d
for
)
for
Area)/Native Cells
Ventricle
Ventricle
per Area))*100

Left
A
Right

Left
B
Right

1
2
3
4
1
2
3
4
1
2
3
4
1
2
3
4

385
425
711
329
1620
1740
1086
485
752
2425
518
3240
1624
1707
2094
995

10.703
11.641
6.794
10.325
10.003
9.566
7.233
4.968
6.189
6.854
4.463
6.864
9.420
11.985
12.323
6.780

36.0
36.5
104.7
31.9
161.9
181.9
150.2
97.6
121.5
353.8
116.1
472.0
172.4
142.4
169.9
146.8
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52.2

35.0

2.7

147.9

36.0

7.6

265.9

176.5

13.8

157.9

15.5

8.1

Bioreactor Design

B

A
3

4

2
1

5

6
C

D

Figure 27: Bioreactor design. (A) Bioreactor components consisting of 1, acrylic rings
used as spacers for positioning cage inside of chamber, 2, chamber lid, 3, chamber, 4,
cage, 5, cage lid, 6, screws and washers used to attach assembled device to the end-overend rotator. (B) Representative image of bioreactor and end-over-end rotator in use
during cell seeding experiment. Red fluid is cell culture medium, black arrow points to
caged-in heart scaffold. (C) Solidworks designs showing bioreactor components in an
expanded assembly. (D) Assembled bioreactor.
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Figure 28: Endocardium reconstitution experiment 2 histological analysis of native
and regenerated endocardium. (A) DAPI fluorescent nuclear stain, (B) Masson’s
Trichrome stain, and (C) IHC for laminin of samples taken from a native rabbit heart and
the left ventricle, right ventricle, and septum of the cell-seeded scaffold. Bars are 100 µm.
Red and black arrows (A, B) depict cells seeded on ventricular surfaces. Black arrows in
(C) depict brown regions indicating a positive IHC reaction. Native DAPI fluorescent
nuclear stain and Masson’s Trichrome stain images are previously shown in Figure 20 of
this chapter. These images are shown again for comparison.
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Figure 29: Endocardium reconstitution experiment 2 SEM analysis of the
endocardium from left ventricle, right ventricle, and septum samples. (A) Native
heart, (B) decellularized scaffold, and (C) cell-seeded scaffold images at 200x
magnification and 1000x magnification. Native and decellularized scaffold images are
previously shown in Figure 18 in chapter 2. These images are shown again for
comparison.
Table 12: Endocardium Reconstitution Experiment 2 Nuclei Quantified by Image J
Cells per Cells per
Seeding Efficiency: (100Sample Cells per Area Area
Area
((Native Cells per AreaCell
Ventricle Sample
Area
(Cell
Averaged Standard
Reseed Cells per
Count
(mm^2) Count/mm^2)
for
Deviation for
Area)/Native Cells per
Ventricle Ventricle
Area))*100
1
1253 14.852
84.4
2
876 13.611
64.4
Left
3
383 13.370
28.6
55.5
25.2
2.9
4
1074 27.664
38.8
5
1365 22.268
61.3
1
1008 13.042
77.3
2
979 7.534
129.9
Right
3
210 4.006
52.4
101.7
35.1
5.2
4
1062 9.315
114.0
5
484 3.590
134.8
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Table 13: Endocardium Reconstitution Experiment 2 Trichrome Quantified by Image J
Fibrin
Collagen
Standard
Percent
Percent
Deviation
Average
Average

Standard
Deviation

Pore
Standard
Percent Deviation

Heart

Ventricle

Cell Seeded

Left

5.5

3.1

15.6

4.6

46.1

8.8

Cell Seeded

Right

7.6

3.3

27.1

12.2

34.8

10.9

Decellularized

Left

4.5

5.5

24.2

32.7

46.8

10.5

Decellularized

Right

8.0

7.7

7.8

4.7

69.1

6.5

Table 14: Endocardium Reconstitution Experiment 2 Effect Summary from JMP

113

114

115

3.4 Discussion
3.4.1 Endocardium Seeding Experiments
We began researching endothelial cell seeing into the ventricular cavities of
acellular scaffolds by attempting static seeding and centrifugal seeding to find an optimal
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method for delivering cells to the endocardium. Endocardium seeding experiment 1
focused on static seeding. Endothelial cells were delivered into the ventricular cavities of
the decellularized scaffold via syringe injection through the aorta and pulmonary trunk.
Following the conclusion of the experiment, we performed histological analysis on the
cell-seeded scaffold. We cut circular samples from the left and right ventricles of a native
rabbit heart and the cell-seeded scaffold to perform DAPI fluorescent nuclear stain, H&E
stain, and Alcian Blue stain (Figure 19). We discovered cells attached to the ventricular
surface of both ventricles of the cell-seeded scaffold using DAPI fluorescent nuclear
stain, H&E stain, and Alcian Blue stain. Based off the DAPI fluorescent nuclear stain
images, the attached cells remained viable after three days of static incubation. Cells also
infiltrated through the surface pores of the ventricles and adhered to regions of the
subendothelial layers of the endocardium and the myocardium. H&E stain, DAPI
fluorescent nuclear stain, and Alcian Blue stain all supported these findings.
The use of endothelial cells in cell seeding experiments on decellularized
myocardial scaffolds have been referenced in literature.63,75,76 Weymann (2014) perfusion
seeded human umbilical cord-derived endothelial cells into decellularized porcine hearts.
They found variable effectiveness for recellularization with the best results near the site
of injection.76 Using static seeding for delivering cells into cardiovascular tissue
engineered constructs has been used in various research settings.52,79,95 However, static
seeding has a great challenge to overcome. Because of the lack of media circulation,
nutrient and oxygen exchange for seeded cells becomes poor overtime.52 In our
experiment we only allowed the cell-seeded scaffold to remain static in media for 3 days
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before fixing it for analysis. This allowed us to determine the effectiveness of our method
for delivering cells prior to cell apoptosis due to a lack of nutrients and oxygen exchange.
To analyze our results for endocardium seeding experiment 1, we used several
histology stains that have been referenced in literature. H&E stain63,78,87,90,96, DAPI
fluorescent nuclear stain63,75,78,79,87, and Alcian Blue stain78 have all been used by
researchers to analyze acellular heart scaffolds seeded with various cell types.
Following endocardium seeding experiment 1, several changes were made to
our procedures for seeding cells into the ventricular cavities of decellularized scaffolds
and producing results of our studies. After analyzing the results from H&E stains and
Alcian Blue stains, we determined these two stains did not yield any additional
information than DAPI fluorescent nuclear stain, aside from the Alcain Blue stain
revealing glycosaminoglycan content. Glycosaminoglycan content can be used to help
depict the structure of the scaffold. However, we concluded by using Masson’s
Trichrome stain instead, we could analyze more components of the scaffold by staining
for collagen content, muscle fiber content, and cellular content all at once. Moving
forward, we no longer used H&E stain or Alcian Blue stain but continued using DAPI
fluorescent nuclear stain and began using Masson’s Trichrome stain.
Upon analyzing the histological stains for endocardium seeding experiment 1,
we discovered circular samples were difficult for determining the orientation of the
sample. The samples were embedded such that the endocardium, myocardium, and
epicardium would be visible on each section of a histological slide. However, depending
on where the sample was sectioned, each of the four sides of the section could be close to
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equal lengths. Declaring one set of opposite sides the endocardium and epicardium was
made difficult by the lack of tissue present on the histology slides. We decided for all
following experiments where recognizing the orientation of the heart wall was important,
we would cut rectangular samples from the ventricules. This allowed for each tissue
section to have a much longer endocardium and epicardium, improving our ability to
determine the orientation of the heart wall.
After discovering the seeded cells were entering surface pores and attaching
beneath the surface, we decided to pursue maximizing this occurrence as a means of
inducing more cellular attachment. Endocardium seeding experiments 2 and 3 utilized
a centrifugal seeding technique instead of a static seeding technique. A syringe was still
used to inject the cell suspensions into each ventricle through the aorta and pulmonary
trunk. However, instead of allowing the scaffold to set static following cell
administration, we placed the scaffold into a 50mL Bio-Reaction tube and centrifuged it
for 10 minutes at 500G. Our goal was to force the seeded cells into the surface pores of
the ventricles to surround the cells with available attachment sites within the scaffold.
We accomplished this goal with limited success. More cells could be found inside
the myocardium and subendothelial layers of the endocardium for endocardium seeding
experiments 2 and 3 than in endocardium seeding experiment 1. DAPI fluorescent
nuclear stain and Masson’s Trichrome stain of the two ventricles depict these findings
(Figure 20). However, after we quantified the DAPI fluorescent nuclear stain images
using Image J, we discovered samples from the same ventricle had high standard
deviations for cells per area (Table 3). This suggest cells were unable to uniformly
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infiltrate the ventricular surfaces of the acellular scaffold following injection. Instead, the
locations of cell administration inside the ventricles yielded the highest cell densities.
Using centrifugation could have prevented the suspended cells from distributing along
the ventricular surfaces by forcing the cells proximal to the injection site downward,
embedding them into the local surface pores. After performing DAPI fluorescent nuclear
stain quantification by Image J for native rabbit heart samples (Table 2), we calculated
the seeding efficiency of endocardium seeding experiment 3 as a representation of the
number of cells re-introduced into the decellularized heart wall. Our seeding efficiencies
for both ventricles were below 1%. While this would be a poor percentage for tissue
engineering the whole heart, our goal was to recellularize the endothelium lining of the
ventricular cavities.
Similar to the histology stains performed in endocardium seeding experiment 1,
Masson’s Trichrome stain has been used by several researchers for cell-seeding
experiments on decellularized myocardial scaffolds.63,78,96 Additionally, centrifugation as
a cell seeding technique has been previously referenced in literature with limited
success.52,95 Dar (2002) created porous alginate scaffolds 5mm in diameter and 1 mm in
thickness. They seeded the scaffolds with varying cell densities of cardiac cells using a
centrifugation speed of 1000g for 6 mins. Afterwards, they discovered centrifugation
influenced a uniform cell distribution to occur on top of the surfaces and beneath the
surfaces of the porous alginate scaffolds.97 However, one big limitation of their study was
the small size of the alginate scaffolds. Some literature reports suggest centrifugation
may negatively impact the morphology of cells when used to seed them onto constructs.95
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However, our DAPI fluorescent nuclear stain revealed cells with intact circular nuclei,
indicating cell viability after centrifugation.

3.4.2 Coronary Seeding Experiments
We designed a seeding device composed of a stand and funnel to assist with
gravitational cell seeding. (Figure 21). Our seeding device attached and supported our
scaffold at the cannulation while not contacting the scaffold’s surface. We designed our
seeding device to inhibit contact with the scaffold’s surface to ensure regions of the
coronary vasculature were not impeded by contact with a foreign object during cell
seeding. This was important to us because we did not want to reduce potential flow
through any of the coronary vessels. Additionally, the funnel allowed us to administer
cells through a stopcock. The stopcock was used to slow down the speed of the cell
suspension. To successfully seed cells into the coronary vasculature, we needed to apply
gentle pressure to the aortic valve to influence the aortic valve to close. By closing the
aortic valve, the only remaining pathways for the cell suspension to flow was into the left
and right coronary branches.
After designing and 3-D printing the seeding device, we began coronary seeding
experiment 1 by administering endothelial cells tagged with immunofluorescence into a
decellularized scaffold. After imaging the scaffold with an IVIS machine (Figure 22), we
confirmed cells adhered to the coronary vasculature along the large vessels of the left and
right branches. However, we did not see evidence of cells seeded into the small vessels of
the coronary vasculature. This suggest the cell suspension followed the path of least

121

resentence through the coronary vasculature by primarily flowing through large vessels
until reaching the coronary sinus. We also discovered the scaffold itself may provide
background fluorescence due to the fluorescing superior and inferior vena cava and
pulmonary veins and arteries. To verify cellular attachment to the large vessels of the
coronary vasculature, we cut rectangular sections of regions containing the right coronary
artery and left coronary/circumflex artery from our cell-seeded scaffold to perform
histology. DAPI fluorescent nuclear stain and Masson’s Trichrome stain revealed cells
adhered to vessel walls.
Gravitational seeding has been referenced in literature many times for seeding
cells into vasculature protheses.95,98 However, in these studies the term gravitation
seeding was often interchangeable with static seeding.95 To distinguish the difference
between endocardium seeding experiment 1 using static seeding and our coronary
seeding experiments 1 and 2 using gravitational seeding, it is important to note that in
our static seeding experiment the cell suspension remained stationary after administration
while in our gravitational seeding experiment, the cell suspension continued to flow
following administration due to the force of gravity. In literature, these terms for seeding
are interchangeable because once a cell suspension is static, the only force acting on cells
is gravity pulling them towards the scaffold.98
In cell seeding experiments, other researchers have also reported the use of cell
tracer kits to verify the location of their adhered cells on scaffolds.99 Additionally,
endothelial cell seeding through the aorta has been previously performed according to
literature.63,75,76 Robertson (2014) attempted three cell seeding techniques to re-
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endothelialize the surfaces of the ventricular cavities of decellularized rat hearts. Out of
these three cell administration techniques, all involved endothelial cells entering the aorta
either through the brachiocephalic artery or directly into the aorta itself.75 Ott (2008)
performed antegrade perfusion of endothelial cells through the aorta of decellularized rat
hearts. In his study, he not only found endothelial cells adhered to the surfaces of the
ventricular cavities but also adhered to the lumen of large and small coronary vessels in
the myocardium.63 Weymann (2014) attempted a scale up study by perfusion
administration of cardiac cells through the aorta of a decellularized porcine scaffold.
Following administration of several cardiac lineage cells, they discovered monolayer
patches of endothelial cells were adhered inside the coronary vasculature partially
covering the endothelium.76 However, in these studies, endothelial cells were
administered using perfusion with the intent of bypassing the aortic valve. In our study
we aimed at closing the aortic valve to allow greater entry into the coronary vasculature.
Regardless, these literature findings help confirm the applicability of seeding endothelial
cells into the coronary vasculature by administering cells through the aorta.
To verify the reproducibility of the histology results from coronary seeding
experiment 1 and to determine the distribution of the seeded endothelial cells in the
coronary vasculature, we attempted coronary seeding experiment 2. The second
coronary experiment was performed with the same protocol as the first coronary seeding
experiment except the endothelial cells were not tagged with a cell tracer. The histology
conducted afterwards verified the reproducibility of the histology results from coronary
seeding experiment 1. Nuclei quantified from DAPI fluorescent nuclear stain images by
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Image J from coronary seeding experiment 2 revealed the highest cell density was at
the coronary sinus (Table 5). The large vessels of the left branch and right branch of
coronary vasculature yielded similar results for cell densities. These findings support our
theory of the cell suspension following the path of least resistance through the coronary
vasculature. If the cell suspension were to flow mainly through the large vessels and stop
at the coronary sinus, we would expect the coronary sinus to have the largest cell density
after the experiment concluded. To quantify the seeding efficiency’s in the regions
containing large coronary vessels, we first used Image J to quantify the nuclei of native
heart samples from the same regions stained with DAPI florescent nuclear stain (Table
4). Afterwards, we found the seeding efficiency’s to be 0.203%, 0.134%, and 0.123% for
the coronary sinus, left coronary artery, and right coronary artery respectively. Similar to
endocardium seeding experiment 3, our seeding efficiencies for coronary seeding
experiment 2 was below 1%. While this is a poor percentage for recellularizing the
entire regions quantified, our goal was to seed endothelial cells onto the endothelium of
the coronary vasculature.

3.4.3 Hydrogel Infusion Experiments
After performing experiments for recellularizing the coronary vasculature and
ventricular endocardium, we decided to move forward with recellularizing the
endocardium as the primary focus of this project. To improve cellular adhesion to the
ventricular endocardium, we decided to incorporate hydrogels into our experiments.
Instead of seeding cells on the surface and inside the pores of the subendothelial
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endocardium layers, we transitioned to applying hydrogels prior to cell seeding to yield a
more favorable environment for cellular adhesion and activity. Additionally, applying
hydrogels could compensate for the partial distribution of the basal lamina following
decellularization. However, by infusing hydrogels into the ventricles of our scaffolds, the
surface pores originally utilized by cells in endocardium seeding experiments 2 and 3
may become filled with hydrogel instead. This changes our strategy of recellularizing the
endocardium from embedding cells into the scaffold to recreating the whole endocardium
on top of the ventricular surface.
Collagen and fibrin hydrogels have been used with various cell lines in literature.
Collagen hydrogels have been shown to have better mechanical properties than fibrin
hydrogels, while fibrin hydrogels have been shown to induce more endothelial cell
activity and communication than collagen hydrogels.100,101 By including a collagen
hydrogel in the ventricles of our scaffold, we could supply the scaffold’s extracellular
matrix with collagen proteins for structural support. Also, using a fibrin hydrogel with
endothelial cells could induce more cellular activity, influencing the cells to secrete some
of the proteins of the basal lamina negatively impacted by decellularization.
Rao (2012) tested varying ratios of mixed collagen-fibrin hydrogel concentrations
with mesenchymal stem cells and endothelial cells. They discovered, by increasing the
amount of fibrin included in the collagen-fibrin hydrogels, the amount of vessel like
formations secreted by the cells also increased.100 This is evident of fibrin hydrogels
inducing cellular communication and activity through influencing cells to form vessel
like channels with one another. Cummings (2004) researched gel compaction with
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smooth muscle cells suspended in either collagen, fibrin, or a 50/50 mixture of collagenfibrin hydrogels. The 50/50 mixture of collagen-fibrin hydrogels yielded the same gel
compaction as fibrin hydrogels but more gel compaction than collagen hydrogels.101
When seeded cells induces a hydrogel to compact, the result is an increase in cell density
due to a smaller volume of hydrogel. This is useful to our research because we can create
a more cell dense reconstituted endocardium if the cells are suspended in a hydrogel that
condenses on the ventricular surface of our scaffold.
To begin incorporating collagen-fibrin hydrogels to our experiments, we first
researched if lyophilizing our scaffold would create a more favorable environment for
integrating the hydrogels. Circular scaffold samples were either left untouched (wet
tissue) or lyophilized before administering a mixed collagen-fibrin hydrogel on top of the
scaffold. Masson’s Trichrome stain revealed wet tissue yielded more hydrogel integration
into the scaffold’s pores while lyophilized tissue resulted in the hydrogel primarily
adhered to the scaffold’s surface (Figure 23). However, these results are not consistent
with the effect of lyophilizing tissue on improving cellular infiltration in literature.
Lyophilization has been used in other tissue engineering applications such as
developing tissue engineered cartilage. Nettles (2002) lyophilized chitosan scaffolds and
seeded them with chondrocytes. The lyophilization was performed to increase porosity
with the rationale of a more porous scaffold would induce more cellular infiltration,
resulting in a uniform cell density.102 Freytes (2008) seeded equal concentrations of
fibroblast onto either lyophilized or wet decellularized porcine urinary bladder samples.
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After 7 days of cell culture on the scaffolds, more cells were found in the lyophilized
samples than the wet samples.103
We believe our results from hydrogel experiment 1 are inconsistent with the
findings in literature for two reasons. One, our scaffold does not have many surface
pores. In our decellularized scaffold SEM images (Figure 18), the surface of our scaffold
appeared to be confluent. However, in endocardium seeding experiments 1-3 we could
seed cells beneath the surface of our scaffold, suggesting the existence of some surface
pores. Second, the lyophilized scaffold samples did not have fluid surrounding them for
the duration of the experiment. This allowed the hydrogel to remain on top of the samples
while solidifying. Because the well plates containing the wet samples did have media
filled to the surface of the samples, the hydrogel administered to these samples could
have flowed into the media. This would allow the hydrogel to diffuse into the large
circumferential pores from the sides of the sample and solidify. After analyzing the
results from hydrogel experiment 1, we decided to move forward without using
lyophilization. Since the hydrogel could not infiltrate beneath the surface of the
lyophilized scaffold, lyophilizing the scaffold would only create larger pores beneath the
surface rather than provide entryways for hydrogels to intimately fuse within the scaffold.
To maximize hydrogel attachment to the ventricular surface, we decided to
include rotation and centrifugation into our methods for administering the mixed
collagen-fibrin hydrogel. Rotation was incorporated to influence the hydrogel entrapped
in the ventricles to coat the entire ventricular surface. Centrifugation was included to
force the hydrogel into any potential surface pores. To accomplish rotation, we designed
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an adaptor plug to be used with an acrylic chamber and metal ring originally designed for
housing an aortic root. The chamber mounted onto an end-over-end rotator that used
LabVIEW to control speed, duration, and number of rotation cycles. The adaptor plug
was designed to secure our scaffold at the bottom of the chamber, limiting the available
room for the scaffold to move while rotating. This was important to us because we did
not want the seeded cells to experience impact forces that may affect viability. However,
we also took into consideration of limiting too much space by applying pressure on the
scaffold and causing the filled ventricles to leak. To incorporate this rotation technique
with cell seeding experiments, we also designed multiple holes in the adaptor plug. The
holes were strategically placed to allow circulation for cell media to supply nutrients and
oxygen to a cell-seeded scaffold.
For hydrogel experiment 2, gravity was used to administer a mixed collagenfibrinogen hydrogel into both ventricles of the decellularized scaffold through the aorta
and pulmonary trunk. After rotation and centrifugation, excess hydrogel solution was
removed from the ventricles and replaced with a thrombin solution. We administered the
thrombin solution separately to prevent the fibrin portion of the hydrogel from solidifying
before removing the excess hydrogels from the ventricles.
Samples taken from hydrogel experiment 2 were embedded one of two ways.
Either oriented along the ventricular circumferential axis to produce histological slides
with a visible endocardium, myocardium and epicardium or oriented along the ventricular
perpendicular axis to produce histological slides with a visible myocardium. This allowed
use to view pores from two different direction and assess if the hydrogel was infusing in

128

one direction better than the other. Masson’s Trichrome stain revealed hydrogel solidified
inside the pores of the scaffold in both orientations (Figure 25). Image J was used to
quantify the collagen (blue) area, fibrin (red) area, and pore area of the Masson’s
Trichrome images. We performed a student’s t-test on decellularized samples and
hydrogel infused samples taken from the same ventricle and orientated in the same
position. We found a significant difference (p-value=0.01) in the collagen percent of the
right ventricle samples embedded on the ventricular perpendicular axis. All other
comparisons did not reveal a significant difference. However, the standard deviations
were large compared to their respective averages for many of the decellularized scaffold
samples. This may reflect poorly on the consistency of some of the chemicals from
Masson’s Trichrome stain on decellularized tissue.
Further statistical analysis was performed using JMP. We discovered sample
orientation cumulatively yielded a significant difference (Table 7). To determine if this
discovery holds true for all the data sets (collagen percent, fibrin percent, and pore
percent) we performed a three-way factorial ANOVA for each data set (Tables 8-10). We
discovered a significant difference in orientation for collagen percent and pore percent
but not for fibrin percent. Next, we used linear contrasts to determine if the orientation
effect was significantly different for both the hydrogel heart and the decellularized heart
in each data set. In the linear contrasts for collagen percent and pore percent, we found a
significant difference for the orientation effect occurred for hydrogel samples but not for
decellularized samples. Similar to the three-way factorial ANOVA, fibrin percent did not
have a significant difference for either heart in the linear contrasts.
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If the orientation effect were to be true for both hearts in the collagen percent and
pore percent data sets, then there would not be a significant difference created by infusing
the hydrogel. However, since this orientation effect holds true for only the hydrogel
infused heart, then it is an indication of the hydrogel infiltrating in one direction better
than the other. This is important to us because we want the hydrogel to fill more into
perpendicular pores than circumferential pores. By the hydrogel filling into perpendicular
pores, we can increase surface area for cellular attachment when cell-seeding.
Additionally, the standard deviations were larger for circumferential oriented hydrogel
infused samples than perpendicular oriented hydrogel infused samples. This suggests
there was poor distribution of the hydrogel into circumferential oriented pores. We
believe the orientation effect occurred from centrifugation. The centrifugal force pushed
the fibrinogen and collagen proteins downward against the ventricular surface. This could
have caused the proteins to infiltrate into the perpendicular oriented pores in a greater
magnitude and more consistently than the circumferential oriented pores.
One inconsistency for this data is the lack of significant difference in fibrin
percent for the two orientations. We can confirm the fibrin portion of the hydrogel did
solidify in the images from Masson’s Trichrome stain. However, following this
experiment we realized the calcium concertation needed for the solidification of the fibrin
hydrogel and the phosphate concentration used to buffer the collagen hydrogel may have
interacted when mixed together. An aqueous solution containing phosphate and calcium
may form calcium-phosphate precipitants. If this occurred during the hydrogel
experiment, then the solidification of either collagen or fibrin may have been affected.
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Moving forward we decided to apply the collagen and fibrin hydrogels separately in a
layer-by-layer method to prevent the interaction of calcium and phosphate and to provide
a method for reconstituting the endocardium analogous to native endocardium structure.
It is important to note that hydrogel experiment 2 was performed after endocardium
reconstitution experiment 1. This explains why the layer-by-layer method was not
applied until endocardium reconstitution experiments 2 and 3.
A third hydrogel experiment was not performed to test the hydrogel integration
using the layer-by-layer method. We did not believe a third hydrogel experiment would
add any additional information that cannot be found from quantifying the Masson’s
Trichrome stain images of endocardium reconstitution experiment 2. The only
difference between the Masson’s Trichrome stain of a hydrogel experiment and an
endocardium reconstitution experiment would be the addition of cells and their effect on
fibrin. The effect of cells on fibrin would be a decrease in the amount of fibrin present on
the scaffold. This will not impact the quantification of collagen content. Also, since fibrin
content will be degraded by cells over time, the fibrin content will not impact the longterm change in pore area.

3.4.4 Endocardium Reconstitution Experiments
Before hydrogel experiment 2, we performed endocardium reconstitution
experiment 1 using a mixed collagen-fibrin hydrogel with the addition of cells. We
seeded more cells into the ventricles of both hearts than before to increase cellular
attachment to the ventricular surface. The adaptor plug, acrylic chamber, metal ring, and
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end-over-end rotator was used to provide rotational cell seeding and hydrogel infusion
(Figure 24).
Following the conclusion of endocardium reconstitution experiment 1 we
found multiple patches of cells and hydrogel adhered to the ventricular surfaces of both
hearts. DAPI fluorescent nuclear stain revealed surface regions with cells adhered as
monolayers and multiple layers (Figure 26). Masson’s Trichrome stain confirmed these
findings and additionally depicted regions of hydrogel with mixed blue and red color,
confirming the solidification of both components of our mixed hydrogel. We also found
regions of hydrogel and cells embedded into some of the pores beneath the ventricular
surface. This is evident of cells and hydrogel infiltrating into some of the surface pores.
However, despite our progress with reconstituting the endocardium, were not able to coat
the entire surface of the ventricular cavities with cells and hydrogel. Interestingly, we did
not find hydrogel attached to the surfaces of the ventricles after hydrogel experiment 2.
The addition of cells to the hydrogel may have created a mixture more favorable to
attachment along the ventricular surface.
DAPI fluorescent nuclear stain quantified by Image J revealed much higher
seeding efficiencies than previous endocardium and coronary seeding experiments. The
seeding efficiencies were 2.71, 7.61, 13.78, and 8.13 in the left ventricle of heart A, right
ventricle of heart A, left ventricle of heart B, and right ventricle of heart B respectively
(Table 11). However, the left ventricle of heart B and heart A had a high standard
deviations compared to their respective cells per area averages. This is suggestive of poor
cellular distribution in the left ventricle. In the right ventricle, the standard deviations
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compared to their respective averages were lower than previous cell seeding experiments,
evident of improved cellular distribution.
While performing endocardium reconstitution experiment 1, we discovered the
amount of media that can be stored in the chambers was not large enough to support the
number of seeded cells for more than 12 hours at a time. Additionally, as the end-overend rotator rotated the chambers, the cell seeded scaffold would spend several seconds
every minute engulfed in an air bubble. When filling the chambers with media, we left
room for an air bubble at the top of the chamber for gas exchange with the sterile filters.
As the chamber rotated, the air bubble would travel to the most elevated region of the
chamber. This caused the air bubble to travel to the bottom of the chamber while the
chamber was upside down. During this window of every rotation, the scaffold would rest
on top of the adaptor plug and be suspended in air instead of media. We decided to design
a new bioreactor to resolve these issues.
The bioreactor was designed with multiple desired inputs. We developed a
pyramidal cage for confining the position of the scaffold to the center of the bioreactor
while leaving ample space for media circulation to the scaffold. The acrylic chamber was
designed to be transparent, capable of attaching to the end-over-end rotator, and house
500 mL of cell media. We made a new acrylic chamber lid to permit the attachment of
three sterile filters for improving gas exchange. O-ring seals were used to secure the
pyramidal cage lid and chamber lid in place. However, due to the weight of the
bioreactor, we decided to incorporate screws through the lid of the chamber for attaching
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to the end-over-end rotator. The screws acted to attach the bioreactor to the end-over-end
rotator and add support for securing the chamber lid.
We performed endocardium reconstitution experiment 2 using the new
bioreactor and a modified protocol with a layer-by-layer method for delivering cells and
hydrogels. The first layer was aimed at rebuilding the subendothelial endocardium. In
the tunica propria the primary components are fibroblast cells and a loose connective
tissue composed of collagen.8 We added a collagen hydrogel to the scaffold’s ventricles,
followed by fibroblast cells differentiated from ADSCs, and then an additional coating of
collagen hydrogel. These components would ideally create a layer of loose collagen
fibers with fibroblast embedded into the structure. The second layer was aimed at
developing the endothelial layer of the endocardium. Fibrin hydrogel was applied over
top of the first layer to stimulate endothelial cell attachment and activity. Afterwards we
seeded the ventricles with endothelial cells. The endothelial cells in presence of the fibrin
hydrogel would ideally secrete their own basal lamina components and communicate
with one another to form a dense tightly sealed endothelium.
The results from endocardium reconstitution experiment 2 indicate we had
partial success for rebuilding the endocardium. DAPI fluorescent nuclear stain revealed
multiple regions of cells adhered to the surface of the ventricles (Figure 28). Masson’s
Trichrome stain confirmed these findings and displayed surface areas with collagen and
fibrin hydrogels attached as well. However, these findings were not consistent throughout
the ventricles. Multiple regions did not depict hydrogels or cells adhered to the surface.
Instead of rebuilding the entire endocardium, the endocardium was reconstituted in
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segmented patches along the ventricular surfaces. Also, in the Masson’s Trichrome stain
images, there are some regions of adhered cells and hydrogels lacking components. Some
of the regions did not stain for cells or one or both hydrogels. In multiple patches of
reconstituted endocardium, it is difficult to discern the effectiveness of both layers. The
scaffold naturally stains blue in Masson’s Trichrome stain because of its’ collagenous
structure and cells stain dark red or black. With the scaffold naturally staining blue, some
regions are difficult to determine if or how much collagen hydrogel adhered to the
surface of the ventricles. Additionally, with dark red or black stained cells suspended in
the collagen and fibrin hydrogels, some regions do not have distinct layers of color. This
makes it challenging to assess the presence of all the added components in those patches
of reconstituted endocardium.
Our seeding technique yielded hydrogel and cell infiltration into the coronary
vasculature and some of the pores underneath the surface of the ventricles. DAPI
fluorescent nuclear stain and Masson’s Trichrome stain both yielded evidence of this
occurrence. The same cell seeding stand and funnel used in coronary seeding
experiments 1 and 2 was used in endocardium reconstitution experiments 1-3. A yconnector and two additional pieces of tubing replaced the stopcock to allow flow into
both ventricles of the scaffold. Because hydrogels and cells suspensions filled the left
ventricle through the aorta, the coronary vasculature was also seeded.
IHC staining for laminin and SEM was performed to further confirm the finding
from histological stains and to assess cellular activity. Laminin IHC was counter stained
with hematoxylin to yield a light purple background with dark purple cells. Cells can be
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visualized on the surfaces of ventricles along with regions of positive stained laminin
proteins. Brown regions depicting a positive reaction with laminin were also found in the
coronary vasculature and in some of the pores beneath the ventricle surface. These results
indicate cellular activity through secretion of basal lamina components. SEM images
reveal patches of adhered cells and hydrogels on the ventricle walls (Figure 29). Cells
were intimately integrated with the hydrogels and actively interacting with neighboring
cells.
DAPI fluorescent nuclear stain quantified by Image J revealed a large standard
deviation compared to the cells per area average for the left ventricle (Table 12). This is
indicative of poor cellular distribution in the left ventricle similar to endocardium
reconstitution experiment 1. The odd phenonium of having poor cellular distribution in
one ventricle but not the other may be linked to the coronary vasculature infiltration. The
left ventricle was seeded with hydrogels and cells from the aorta, giving passage way to
both the left ventricle and the coronary vasculature. It is possible that enough of the cell
suspension and hydrogel solutions entered the coronary vasculature to negatively impact
the seeding outcomes in the left ventricle. The seeding efficiencies of endocardium
reconstitution experiment 2 were also similar to endocardium reconstitution
experiment 1 with 2.877 percent of cells re-seeded into the left ventricle and 5.235
percent of cells re-seeded into the right ventricle.
Masson’s Trichrome stain quantified by Image J yielded higher averages for
collagen percent and lower averages for pore percent compared to the same ventricles
and orientation from hydrogel experiment 2 (Table 6, 13). However, majority of the
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standard deviations for the averages between the two experiments are too large to declare
a significant difference by a students t-test. Only pore percent between the right ventricles
yielded a significant difference (p-value=0.02), while all other comparisons for collagen
percent, pore percent, and fibrin percent were not significantly different.
The averages for fibrin percent from endocardium reconstitution experiment 2
are lower than the averages from hydrogel experiment 2. A lower fibrin percent was
expected because cells degraded the fibrin hydrogel over several days of culture in the
scaffold. Also, in endocardium reconstitution experiment 2, the standard deviations
compared to their respective averages were much lower than the standard deviations
compared to their respective averages in hydrogel experiment 2. This suggests the layerby-layer method improved hydrogel distribution. Overall, the data gathered from
hydrogel experiment 2 and endocardium reconstitution experiment 2 were not
conclusive but indicative of the layer-by-layer method yielding a more optimal hydrogel
infusion than applying the hydrogels mixed together.
We used the same data gathered from the decellularized scaffold in hydrogel
experiment 2 to compare with the scaffold from endocardium reconstitution
experiment 2. A student’s t-test was performed on decellularized samples orientated
along the circumferential axis and the reconstituted endocardium scaffold samples taken
from the same ventricle. We discovered a significant difference between the right
ventricle collagen percent (p=.02) and the right ventricle pore percent (p=.0008).
However, we did not find a significant difference between left ventricle collagen percent
and pore percent. This may be explained by the thickness difference between the left
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ventricle and right ventricle. Because the left ventricle is thicker than the right ventricle,
more hydrogel infusion would be needed in the left ventricle of the reconstituted
endocardium scaffold to determine a significant difference from the left ventricle of the
decellularized scaffold. Even though we cannot show a significant difference between the
two left ventricles, there was still enough hydrogel infusion into the left ventricle to make
an impact on the seeded cells.
Using the data from Masson’s Trichrome stain quantified by Image J of
decellularized scaffold samples and reconstituted endocardium samples, we performed a
more in-depth statistical analysis using JMP (Table 14). A significant difference
between the two hearts and an interaction between hearts and ventricles was discovered.
To diagnose the cause of the interaction between hearts and ventricles we performed two
linear contrast for each data set (collagen percent, fibrin percent, and pore percent) to
compare the samples from the left ventricles and compare the samples from the right
ventricles (Table 15-17). The only significant difference discovered was between right
ventricles using the data from pore percent. However, the data between right ventricles
using collagen percent was close to a significant difference with a p-value of 0.11. Based
off these results, we can conclude there was not a significant difference between the left
ventricles of the two scaffolds but there was a difference between the right ventricles of
the two scaffolds. This is in agreeance with the student’s t-test we performed on this data.
We are the first researchers to attempt reconstitution of the endocardium inside
acellular myocardial scaffolds. Our final technique used a layer-by-layer method for
applying each component of the endocardium to our scaffold. Layer-by-layer techniques
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have been used in tissue engineering for other applications. There are several ways to
produce biomaterials using a layer-by-layer method. Each layer can be created with the
ability to attract the next layer. This technique develops multilayered biomaterials with
intimately joined layers. Processes such as charge transfer, biological recognition,
covalent bonding, hydrogen bonding, electrostatic interactions, and hydrophobic
interactions have been referenced in literature for creating layered biomaterials used in
tissue engineering.104 Others have explored rapid prototyping methods for creating each
layer individually and using various techniques to join the independent layers.105 One
particular rapid prototyping method used in tissue engineering for developing organs is 3D printing layers of matrix or cells.106 While these methods relay on computer aided
techniques or interactions between layers for building complex biomaterials, we explored
a different technique for building our reconstituted endocardium. Rotational forces were
applied to our hydrogels and cells to develop a more uniform coating of each layer in the
acellular scaffold’s ventricles and centrifugation forces were applied to force the proteins
and cells to the surface of the previous layer.
Layer-by-layer techniques have also been used with endothelial cells. Boura
(2005) used a layer-by-layer method to develop a biomaterial capped with poly(d-lysine)
(PDL) or poly(allylamine hydrochloride) (PAH). Endothelial cells were seeded on top of
the multilayered biomaterials and seeded on top of PAH monolayers, PDL monolayers,
glasses, and fibronectin-coated glasses for comparison. They discovered the multilayered
biomaterials yielded higher cell viability over several days of culture compared to the
monolayers of PAH and PDL.107,108 Similarly, we discovered using hydrogel layers with
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our cells resulted in greater seeding efficiencies into the ventricles of our acellular
scaffolds.

3.5 Conclusion
Following endocardium seeding experiments 1-3, we determined our
decellularized scaffold can support cellular attachment and viability. Static seeding used
in endocardium seeding experiment 1 resulted in cells attached to the ventricular
surfaces of the scaffold. Cells were also able to infiltrate through the surface pores of the
ventricular cavities and adhere to attachment sites within the subendothelial layers of the
endocardium and adhere to the myocardium. Endocardium seeding experiments 2 and
3 yielded more cellular attachment beneath the surface of the ventricular cavities by using
centrifugation. However, DAPI fluorescent nuclear stain images quantified for cell nuclei
by Image J revealed poor cellular distribution in both ventricles of the scaffold.
Based off the results from coronary seeding experiments 1 and 2, we
determined our seeding device and technique can effectively induce endothelial cells to
infiltrate the large vessels of the coronary vasculature. However, we were unable to
effectively seed endothelial cells into the smaller vessels. By using Image J to quantify
the nuclei from the DAPI fluorescent nuclear stain images, we discovered the coronary
sinus yielded the highest cell density and seeding efficiency. The right and left coronary
arteries yielded similar results for cell densities and seeding efficiencies compared to one
another.

140

After hydrogel experiment 1, we decided against lyophilization of scaffold prior
to hydrogel infusion and cell seeding. Lyophilization increased the size of the pores
beneath the ventricular surface but did not impact hydrogel infiltration into those pores.
In hydrogel experiment 2 we discovered our procedure induced hydrogel infiltration
beneath the surface of the ventricles but did not induce hydrogel adhesion to the surface.
Using JMP to perform statistical analysis on the data generated by Image J from
Masson’s Trichrome stain images, we concluded the hydrogel infiltrated pores oriented
along the ventricular perpendicular axis better than pores oriented along the ventricular
circumferential axis.
Our endocardium reconstitution experiments 1 and 2 yielded patches of
reconstituted endocardium along the ventricular surfaces of our scaffolds. DAPI
fluorescent nuclear stain and Masson’s Trichrome stain depict this occurrence in
endocardium reconstitution experiments 1 and 2. Based off the data generated by
Image J quantification of DAPI fluorescent nuclear stain images, our cell seeding and
hydrogel infusing techniques yielded improved cellular adhesion in both ventricles and
cellular distribution in the right ventricle compared to previous cell seeding experiments.
After adapting a layer-by-layer method for reconstituting the endocardium, Masson’s
Trichrome stain images quantified by Image J showed an improvement for hydrogel
distribution in both ventricles. Additionally, histological analysis and SEM images
revealed hydrogel adhered on the surface of both ventricles. Laminin IHC and SEM
images depicted cells interacting with one another, secreting basal lamina proteins, and
intimately integrated with the hydrogels. However, our major limitation in these studies
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was the inability to cover the whole ventricular surface with our reconstituted
endocardium. Instead, we were only able to apply patches of reconstituted endocardium
dispersed throughout the ventricles.
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CHAPTER FOUR
CONCLUSIONS AND RECOMMENDATIONS FOR THE FUTURE
4.1 Summary of Project Significance
Myocardial infarction is one of the leading causes of death in the world. Each
year, more than 7 million people are estimated to have myocardial infarction.17
Cardiovascular disease as a whole in the United States had an estimated $316.6 billion
dollar cost in 2012. As a comparison, in 2012 the estimated cost for cancer was $88.7
billion dollars in the United States.1 Myocardial infarction and other related heart
diseases are responsible for a large portion of the estimated cost for cardiovascular
disease. Despite the outstanding need for more treatment options, the optimal treatment
method for heart failure remains to be heart transplantation. Unfortunately, heart
transplantation is a treatment method uncapable of meeting the outstanding need for
treatment.2 Each year multiple people die while on the waitlist to receive a donor heart.
Other treatment methods have been shown to prolong life but do not fully restore
function nor heal the damaged regions of myocardium.3,46
There is obvious room for improvement and a clear need to develop alternative
methods for treating congestive heart failure. Our approach is based on cardiovascular
tissue engineering using acellular heart scaffolds. The end goal of our work is to develop
a fully recellularized functional tissue engineered heart made from a decellularized
xenogeneic or cadaveric heart scaffold and a patient’s own cardiac lineage cells. To
obtain our end goal, each layer and component of the heart must be fully restored on a
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decellularized scaffold. This project focused on rebuilding the endocardium layer of the
ventricles inside an acellular heart scaffold.

4.2 Summary of Advancement Toward Completion of Specific Aims
4.2.1 Aim 1: To develop and characterize an acellular rabbit myocardial scaffold
through bi-ventricular perfusion decellularization.
Whole rabbit hearts were successfully decellularized using a bi-ventricular
perfusion decellularization system. This procedure yielded four decellularized rabbit
hearts with preserved ventricular cavity surface structure and shape. Decellularization
was assessed by color change from native burgundy to decellularized snow-white, DNA
loss depicted in nanodrop spectrometry, lack of DNA content from gel electrophoresis,
and the absence of cellular content in images from DAPI fluorescent nuclear stain,
Masson’s Trichrome stain, and SEM. Masson’s Trichrome stain and SEM images also
revealed ventricular structure and majority of the extracellular composition was retained.
However, IHC staining for the basal lamina components depicted partial distribution of
the basal laminin.
4.2.2 Aim 2: To reconstitute the endocardium inside the acellular ventricular
cavities with clinically relevant hydrogels and cell types.
After sterilizing decellularized rabbit heart scaffolds, collagen and fibrin
hydrogels, endothelial cells, and fibroblast cells differentiated from ADSCs were
administered into the ventricles in a layer-by-layer technique. A total of two layers were
applied to the endocardial surface of the acellular ventricles. The first layer consisted of
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two collagen hydrogel coatings with fibroblast cells in between to recreate the loose
collagenous structure of the subendothelial layer of the endocardium. The second layer
consisted of a fibrin hydrogel coating followed by endothelial cells to rebuild the
endothelium layer of the endocardium. DAPI fluorescent nuclear stain and Masson’s
Trichrome stain images revealed cells and hydrogel attached in segmented patches along
the ventricles’ surfaces. SEM images and images from IHC stained for laminin protein
supported these findings and additionally showed cells integrated with the hydrogel,
interacting with neighboring cells, and actively secreting basal lamina proteins. Also,
histological stains depicted cells and hydrogel infiltrated in some of the pores beneath the
ventricular surfaces and in the coronary vasculature. Previous cell seeding experiments
showed acellular rabbit heart scaffolds support cell viability.

4.3 Recommendations for Future Studies
4.3.1 Overview
This research project is aimed at reconstituting the endocardium in ventricular
cavities of decellularized whole heart scaffolds. The long-term goal is to develop a tissue
engineered functional whole heart for the transplantation need of patients with an end
stage heart disease. To continue to work towards this end goal, there are several aspects
of this project that can be improved upon and further researched. Decellularization of
whole rabbit hearts, reconstitution of the endocardium, and methodology for obtaining
results are all areas capable of improving.
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4.3.2 Decellularization of Whole Rabbit Hearts
The major drawback of our decellularization procedure is the partial removal and
disruption of the basal lamina. Literature reports have suggested the use of detergents in
decellularization have resulted in the removal or disruption of extracellular matrix
components.60 Our procedure utilizes 5 cycles of SDS rinses with each cycle lasting four
days at a time. Jessica Canavan (2016) previously worked on decellularizing whole rabbit
hearts. She decellularized more than 4 rabbit hearts at once while only perfusing into the
left ventricle. Her decellularization procedure used the same concentration of SDS and
number of days per SDS cycle as our decellularization procedure. After completing
decellularization, her work suggested only three cycles of SDS were needed to effectively
decellularize multiple left ventricles of whole rabbit hearts.91 Our decellularization
system perfuses fluids into both ventricles of four rabbit hearts. One possible method for
improving the basal lamina retention of our scaffolds, would be to reduce the number of
SDS cycles until the minimum is used for effectively decellularizing the whole rabbit
hearts. DNA content should be assessed after each SDS cycle by a combination of
techniques using either color change, nanodrop spectrometry, gel electrophoresis,
histology, or SEM.

4.3.3 Reconstitution of the Endocardium
There are two areas of improvement for reconstituting the endocardium. The first
is improving the layer-by-layer method to increase hydrogel and cellular attachment and
uniformity across the ventricular surfaces. Several methods can be explored for
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improving this aspect. One method is incorporating electrostatic interactions when
applying the collagen hydrogel. Literature reports indicate several techniques have been
used for attracting each layer of a layer-by-layer method such as charge transfer,
biological recognition, covalent or hydrogen bonding, and electrostatic or hydrophobic
interactions.104 Utilizing electrostatic interactions could be accomplished by incubating
the scaffold in a basic solution followed by adjusting the pH of the collagen hydrogel to
be acidic. Once collagen proteins are past their isoelectric point, they will develop an
affinity for accepting electrons. After incubating the scaffold in a basic solution, the
positively charged collagen proteins would be attracted to the electron donor molecules
embedded in the scaffold. This may influence the collagen proteins to infiltrate the
surface of the scaffold more intimately before solidification. Careful consideration would
need to be taken to not damage, degrade, or alter the scaffold and collagen hydrogel.
Additionally, the hydrogel infused scaffold would need to be neutralized to be compatible
with cell seeding.
Another route for improving collagen hydrogel infusion is to decrease the
concentration of collagen protein in the hydrogel solution and let the solution set
overnight in the ventricles to solidify. This approach is analogous to our method for
creating the fibrin hydrogel on the surfaces of the ventricles. The collagen hydrogel
solution would be rotated and centrifuged inside ventricles of the acellular scaffold for
uniformity and solidification on the surface. The small concentration of collagen proteins
would ideally be centrifuged to the surface of the ventricles to create a layer of collagen
hydrogel after overnight incubation.
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Methods that can be explored for improving cell viability are reducing the number
of endothelial cells seeded at once and reducing the incubation time the cells are sealed
inside the ventricles for cellular attachment. Seeding millions of endothelial cells at once
may be determinantal to cell viability because of the limited availability of nutrients.
Because the ventricles were sealed for overnight incubation to ensure the seeded cells do
not flow out of the ventricles, the media in the cell suspension may not contain enough
nutrients to support the large number of seeded cells for the duration of time. Reducing
the number of cells seeded at once may improve cell viability by not utilizing the
available nutrients as quickly. Seeding steps could be repeated to ensure millions of
endothelial cells are still seeded into the ventricles. Reducing the incubation time from
overnight to 4-6 hours would still allow enough time for cellular attachment while
reducing the time span the seeded cells are sealed off from the available nutrients and
oxygen in the media stored inside the bioreactor.
Development and implementation of a perfusion bioreactor would also improve
endocardium reconstitution. The rotation bioreactor system is capable of supporting cell
viability to an extent. Eventually, media flow will be needed to support cell proliferation
and viability for longer-term studies. Additionally, introducing flow to the patches of
reconstituted endocardium will explore the effect of shear on the durability of the
reconstituted endocardium. Also, experiments will need to be performed for longer
durations to discover the final condition of the reconstituted endocardium after the seeded
cells have degraded the fibrin hydrogel and secreted basal lamina proteins. Ideally, the
perfusion bioreactor would start at low flow and ramp up to physiological conditions.
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Incorporating pulsatile flow and a method for inducing ventricular contractions, would
further improve scaffold conditioning. For our reconstituted endocardium to have clinical
relevance, the reconstituted endocardium must be able to withstand physiological
conditions.
Additionally, to show clinical relevance, the scaffold will need to be mechanically
tested. Assessing mechanical performance was not done in our study but is highly
recommended in future studies, especially after the development of a perfusion
bioreactor. Mechanical testing would verify the reconstituted endocardium and scaffold
itself can withstand physiological stresses and function under in vivo conditions. Also,
mechanical stimulation could be incorporated during the experimental procedure.
Mechanically stimulating the hydrogels may improve solidification uniformity along the
surface of the ventricles and condition the scaffold prior to assessing mechanical
performance.
In our study, we showed hydrogels and cells seeded into the coronary vasculature
and myocardial pores produced a favorable environment for cells to secrete structure
proteins. While this helps replenish some of the basal lamina proteins lost during
decellularization, infusing hydrogels into the coronary vasculature is not ideal. Seeding
vascular cell lines into the coronary vasculature will eventually be needed for
recellularizing the whole myocardial scaffold but infusing hydrogels into the coronary
vasculature may occlude some of the vascular network depending on how well cells can
degrade and restructure the hydrogels. One method for preventing hydrogels from
entering the coronary vasculature would be to design and implement a longer cannula for
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cannulating the aorta. The longer cannula would need to bypass the aortic valve and
administer the hydrogels directly into the left ventricle. Another method for preventing
the hydrogels from entering the coronaries is ligating the coronaries prior to
administering the hydrogels.

4.3.4 Methodology for Obtaining Results
All histology, IHC, and SEM data gathered across every experiment was
performed on scaffolds or hearts fixed static in formalin. In vivo, the heart is under
pressure from blood perfusion. To adequately ascertain the results from decellularization
and reconstitution experiments, scaffolds should be perfusion fixed in formalin and
compared to native hearts perfusion fixed in formalin. This will yield representative
images of the endocardium seen under natural conditions.
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